Stock Report

Do not mistake temptation for opportunity.

Generated Wed May 02 09:19:01 EDT 2018.

Ratings are relative rankings calculated by finding the lower bound of Wilson score confidence interval. A rating value close to 1 means a higher probablity of a stock's price high vs price open hitting or exceeding Calculated Target.

Mood

Today's mood: 0.4416328811129277

Watched Stocks

Symbol	Rating	Buy	Sell

Leads

These 16 stocks represent the top 2% of all considered stocks. 2% = 14

Symbol	Rating	Buy	Sell	Mass	Min	Max	Mean	Median	Stdev
⬇$AJG¹⁾	0.785	14	0	17	0.117%	0.807%	0.401%	0.445%	0.233
⬇$EXPD²⁾	0.757	12	0	8	0.000%	2.694%	0.634%	0.354%	0.785
⬇$HP³⁾	0.757	12	0	5	0.476%	1.774%	1.025%	0.811%	0.532
⬇$JNPR⁴⁾	0.739	35	5	68	0.153%	3.810%	1.258%	1.025%	1.101
⬇$INCY⁵⁾	0.722	10	0	27	n/a	n/a	n/a	n/a	n/a
⬇$BSX⁶⁾	0.701	9	0	18	0.169%	3.059%	0.688%	0.371%	0.860
⬇$MYL⁷⁾	0.621	13	2	26	0.078%	2.000%	0.925%	0.887%	0.594
⬇$AME⁸⁾	0.610	6	0	26	0.161%	5.970%	0.992%	0.413%	1.764
⬇$WY⁹⁾	0.610	6	0	9	0.201%	3.191%	0.788%	0.482%	0.891
⬇$A¹⁰⁾	0.598	32	11	62	0.192%	0.913%	0.463%	0.363%	0.227
⬇$HES¹¹⁾	0.570	13	3	8	0.000%	2.020%	0.785%	0.672%	0.623
⬇$XRX¹²⁾	0.567	15	4	108	0.000%	1.692%	0.847%	0.799%	0.482
⬇$AA¹³⁾	0.566	5	0	6	0.144%	4.301%	1.579%	1.533%	1.278
⬇$GILD¹⁴⁾	0.564	111	63	363	0.000%	2.750%	0.848%	0.685%	0.845
⬇$HAL¹⁵⁾	0.552	10	2	12	0.321%	3.752%	1.202%	0.770%	1.113
⬇$NFX¹⁶⁾	0.527	13	4	28	0.333%	2.738%	1.128%	0.832%	0.747

$AJG

RT @earningscast: $AJG Listen to Q1 2018 Arthur J. Gallagher & Co. Earnings Call live at 05:15 PM, ondemand after - https://t.co/L3rH2w2VSX
RT @earningscast: $AJG Listen to Q1 2018 Arthur J. Gallagher & Co. Earnings Call live at 05:15 PM, ondemand after - https://t.co/L3rH2w2VSX
$AJG New Form 8-K for Arthur J. Gallagher & Co. From our Stock News Alerts App
$AJG Listen to Q1 2018 Arthur J. Gallagher & Co. Earnings Call live at 05:15 PM, ondemand after - https://t.co/L3rH2w2VSX
$AJG: New SEC Filing for AJG: Form 8-K (No. 0001193125-18-146700): https://t.co/MXH2OhxNmb
The most accurate $AJG estimate is from rama2050, beating 10 other analysts and the Wall Street Consensus - https://t.co/LTaXzI5jXY
$AJG beats the Estimize EPS Consensus by 4c and the Estimize Revenue Consensus by $172.08M - https://t.co/68NFBAImvW
$AJG reports FQ1 earnings of $1.52 EPS and $1.80B Revs - https://t.co/S7tpCfaF26
Arthur J. Gallagher & Co. $AJG Posts Quarterly Earnings Results, Beats Estimates By $0.97 EPS https://t.co/RKqgVUbqRZ
Arthur J. Gallagher & Co. $AJG Issues Quarterly Earnings Results, Beats Estimates By $0.97 EPS https://t.co/HyGTOb33vT
Arthur J. Gallagher & Co. $AJG Releases Earnings Results, Beats Estimates By $0.97 EPS https://t.co/IL1wRZSVqm
RT @WarrenBuffetHQ: Even the foolish can attain wisdom by being modest The Best Stock Investment For 2018 https://t.co/7jGxMoJqTc $AMH $MGA…
Arthur J. Gallagher & Co. $AJG Receiving Somewhat Positive Media Coverage, Study Shows https://t.co/lbTIOjcchj
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Arthur J. Gallagher & Co. $AJG Share Price https://t.co/BWwraRR0XD
Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Arthur J. Gallagher & Co. $AJG Share Price https://t.co/ZDlsOrCixs
Arthur J. Gallagher & Co. $AJG Posts Quarterly Earnings Results https://t.co/m5IlcYa20i
Arthur J. Gallagher & Co. $AJG Given a $78.00 Price Target at Wells Fargo https://t.co/iJXuBQsfhH

$EXPD

RT @SeekingAlpha: $AAPL #APPLE $ADP $ARTNA $BG $CAH $CFR $COST $CTWS $EXPD $FDS $FELE $FLO $FUL $GWW $IBM $JNJ $LEG $LOW $MSA $PBCT https:/…
$AAPL #APPLE $ADP $ARTNA $BG $CAH $CFR $COST $CTWS $EXPD $FDS $FELE $FLO $FUL $GWW $IBM $JNJ $LEG $LOW $MSA $PBCT https://t.co/7oQxWjVYes
Retweeted Seeking Alpha (@SeekingAlpha): $AAPL #APPLE $ADP $ARTNA $BG $CAH $CFR $COST $CTWS $EXPD $FDS $FELE $FLO… https://t.co/Q7HCCqMxH6
RT @SeekingAlpha: $AAPL #APPLE $ADP $ARTNA $BG $CAH $CFR $COST $CTWS $EXPD $FDS $FELE $FLO $FUL $GWW $IBM $JNJ $LEG $LOW $MSA $PBCT https:/…
RT @SeekingAlpha: $AAPL #APPLE $ADP $ARTNA $BG $CAH $CFR $COST $CTWS $EXPD $FDS $FELE $FLO $FUL $GWW $IBM $JNJ $LEG $LOW $MSA $PBCT https:/…
Expeditors International $EXPD Lifted to Buy at ValuEngine https://t.co/9Xj0uXpFei
Expeditors International $EXPD Lifted to Buy at ValuEngine https://t.co/958H4XZ6eM
$EXPD Max Pain is 55.00 for maturity 05/18/2018. #maxpain #options https://t.co/pIe2w7rpph https://t.co/pGqnVXgvEO

$HP

RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $MRK $LYG $USB $EBIO $MZEI $TXN $APHD $HPNN $JNJ $S $HP…
Somewhat Favorable News Coverage Somewhat Unlikely to Impact Helmerich & Payne $HP Share Price https://t.co/XqYvzp163S
Ep.160: @Xerox Part II - A Sale Process Coming? https://t.co/80hltwP7oN $XRX $IBM $HP $INFY $CTSH $WIT $GD $SAIC $DXC #xerox
Helmerich & Payne $HP Lifted to “Buy” at ValuEngine https://t.co/TTKKXHLLjC
Helmerich & Payne $HP Lifted to “Buy” at ValuEngine https://t.co/YW0sXNIPr7

$JNPR

RT @MarketCurrents: Juniper Networks +4.1% after Q1 beat https://t.co/eE8XOiJZ13 $JNPR
$JNPR 26.39 +1.65 +6.7% (After Hours) Latest News, Stock Price and Trading Information https://t.co/tccwNH1BMw
Juniper Networks beats by $0.02, beats on revenue https://t.co/AskOzWgVQP $JNPR
JNPR higher after the bell(+3.5%/earnings), heading for big upside gap if this holds, will open above March highs($… https://t.co/rTAYS1ayjc
Juniper Networks +4.1% after Q1 beat https://t.co/brlecneNh3 $JNPR
Juniper Networks +4.1% after Q1 beat https://t.co/eE8XOiJZ13 $JNPR
RT @eWhispers: #earnings after the close $AAPL $SNAP $GILD $COHR $TMUS $PAYC $DVN $SU $WATT $APC $BGFV $JNPR $MDLZ $ALL $FTR $WU $MDLP $CH…
After Hours Movers: $SFLY $CRAY $ACTG $ZEN $BGFV $JNPR $AAPL $SNAP $GILD https://t.co/8mrT5SACLU
@StockTwits Trending via @Stocks_Live #stocks #stockmarket $AAPL $SNAP $GILD $MTCH $I $WATT $SHOP $MA $BSTI $TMUS… https://t.co/6qZCYWjC8m
$JNPR: Juniper Networks beats by $0.03, beats on revs; guides Q2 EPS in-line, revs in-line https://t.co/MQVT3xl916
Do you know that #WallStreet price for $JNPR is $29.12 https://t.co/FQFlYdIyNM
RT @7LadyQ: $JNPR Juniper Networks beats by $0.02, beats on revenue Juniper Networks (NYSE:JNPR): Q1 EPS of $0.28 beats by $0.02. Revenue o…
Wondering about #sentiment indicator for $JNPR? The Short Ratio is 2.73% https://t.co/Cx9UXihQmY
Juniper Networks $JNPR Updates Q2 Earnings Guidance https://t.co/Rm2VKy1Nrs
Juniper Networks $JNPR Updates Q2 Earnings Guidance https://t.co/Gnq8cboQK0
Juniper Networks $JNPR Issues Q2 Earnings Guidance https://t.co/C8bnVyHwJ9
RT @Benzinga: Juniper Networks Q1 EPS $0.28 Beats $0.26 Estimate, Sales $1.0826B Beat $1.05B Estimate; Shares Up 5% After Hours $JNPR htt…
$JNPR $25.37 +0.63 (2.55%) - News Out on Juniper Networks https://t.co/lLa0l2NF67
$JNPR reports Preliminary Q1 2018 Financial Results, stock boosts +1.57%, #JuniperNetworks https://t.co/zdxbNWsy6k
Wondering about risks of $JNPR? The 63-day volatility is 14.29% https://t.co/ww5VUZGio0
$JNPR is in Double Bottom winning 75.00% in the past. https://t.co/ZYsCvwJwx3
$JNPR gains in after hours trading. See the latest news. https://t.co/Y0eICrxZBI https://t.co/A5lNJK1vJB
$JNPR high OI range is 24.00 to 25.00 for option expiration 05/04/2018 #maxpain #options https://t.co/Gbj1QmAlA2 https://t.co/1Ph9qXFJpF
$JNPR #Juniper Networks Inc Juniper’s MX to PTX Struggle Persists, But 1Q Results Above Guidance Midpoints; Maintai… https://t.co/lRzLft4qlV
Recommendation #HOLD for $JNPR with UB rating - 2.79 out of 5. https://t.co/Ogf4pOXYOJ
Juniper Networks $JNPR Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS https://t.co/TIWSCcAvtZ
Juniper Networks $JNPR Announces Earnings Results https://t.co/YRA0CAgUVT
Juniper Networks $JNPR Announces Earnings Results, Beats Expectations By $0.03 EPS https://t.co/xw7J4OKpSX
Wondering about #sentiment indicator for $JNPR? The Short Ratio is 2.73% https://t.co/Cx9UXihQmY
Juniper Networks $JNPR Now Covered by Macquarie https://t.co/UXAgGCdgkb
Juniper Networks $JNPR Now Covered by Analysts at Macquarie https://t.co/yTKDT0eo88
Head to Head Analysis: Juniper Networks $JNPR versus Its Rivals https://t.co/mAef0nlfEg
5-star analyst Ittai Kidron from Oppenheimer maintained a Buy on $JNPR. https://t.co/EDy2nuGtJM
RT @AnalystWire: BofA/Merrill Lynch Upgrades Juniper Networks $JNPR to Buy, 'Revenue growth and margin improvement ... https://t.co/0RnsxAE…
BofA/Merrill Lynch Upgrades Juniper Networks $JNPR to Buy, 'Revenue growth and margin improvement ... https://t.co/0RnsxAED4c
#Premarket Top % Gainers: $HCHC 42%, $SIGA 12%, $TRVN $NANO $AVGR $EVTC $JNPR $CRTO $NVO $DPW $AAPL $FCAU $VVUS… https://t.co/j37vcvdHC0
RT @Super1NYC: #Premarket Top % Gainers: $HCHC 42%, $SIGA 12%, $TRVN $NANO $AVGR $EVTC $JNPR $CRTO $NVO $DPW $AAPL $FCAU $VVUS $CHK $USLV h…
Juniper Networks $JNPR Now Covered by Macquarie https://t.co/QhDJdbxQh8
RT @ACInvestorBlog: Upgrades $TCF $TDS $CATY $UFS $IRWD $MLM $VMC $HFWA $EV $CBD $JNPR $EVTC $FCX $USM $MLM
Upgrades $TCF $TDS $CATY $UFS $IRWD $MLM $VMC $HFWA $EV $CBD $JNPR $EVTC $FCX $USM $MLM
$JNPR subiendo casi un 7% en premarket después de subir ligeramente las previsiones para el segundo trimestre. https://t.co/FYfrY4amRw
21 Stocks Moving In Wednesday's Pre-Market Session https://t.co/xNFFLeayAO $HCHC $SIGA $SFLY $NANO $JNPR $AAPL… https://t.co/fyygnTYNp2
Wondering about risks of $JNPR? The 21-day volatility is 5.5% https://t.co/ww5VUZGio0
$JNPR up on earnings beat, upgrades from DB and BOA
Morning Call For Wednesday, May 2 $JNPR $MLM $BRKS $CRAY $NANO $SFLY $AAPL $BGFV $COHR $GILD $SNAP $MTSI $ZEN $YUMC https://t.co/wvK8YmrE9j
#Premarket Top % Gainers: $HCHC 56%, $TRVN 11%, $NANO $SQNS $EVTC $JNPR $OCN $DPW $AMRN $AAPL $NVO $FCAU $CVS $GRMN… https://t.co/4HkE9Eslzk
Juniper Networks $JNPR Upgraded by Bank of America to Buy https://t.co/GLrjxL31I2
Juniper Networks $JNPR Upgraded by Bank of America to Buy https://t.co/6ZyJeXPTYd
Juniper Networks $JNPR Stock Rating Upgraded by Deutsche Bank https://t.co/xMYkJzWUkE
Watching: $SNAP $HCHC $AVGR $JNPR Earnings: https://t.co/JLmmLXK56s #daytrading #trading #stocks
Gapping up: $SIGA +12.9%, $CRAY +12.5%, $SFLY +10.7%, $TRVN +9.4%, $ENPH +8.9%, $NANO +8.4%, $TC +5.4%, $JNPR +5.1%… https://t.co/U4wIFoAfDM
RT @Super1NYC: #Premarket Top % Gainers: $HCHC 42%, $SIGA 12%, $TRVN $NANO $AVGR $EVTC $JNPR $CRTO $NVO $DPW $AAPL $FCAU $VVUS $CHK $USLV h…
Top 10 $SPY Pre-Market Leaders: $JNPR $SPGI $PBI $AAPL $ADP $WYN $CHK $GRMN $TER $MA Top 10 $SPY Pre-Market Laggar… https://t.co/yQsOyiZDb7
RT @Benzinga: 21 Stocks Moving In Wednesday's Pre-Market Session https://t.co/xNFFLeayAO $HCHC $SIGA $SFLY $NANO $JNPR $AAPL $SNAP $HTBX $S…
21 Stocks Moving In Wednesday's Pre-Market $HCHC $SIGA $SFLY $NANO $JNPR $AAPL $SNAP $HTBX $SSYS $GILD $TAP $W https://t.co/9qG8ONDsc2
Gainers Premarket $HCHC $LITE $JNPR $EVTC $AAPL $GRMN $FCAU $MA $BBL $CNHI $EL $PKX $AU $TS $WBA $RIO $SQ $EWG $CY https://t.co/jpobP3U3HN
Today's top trade ideas: $$ESPR,$MA,$NVO, $DBD, $NANO, $ADP, $GRMN, $LITE, $CVS, $W, $SWKS, $SFLY, $JNPR, $IAC, $MTCH, $AAPL, $UVXY, $TECS
Top 20 $SPY Pre-Market Volume Leaders: $AAPL $CHK $MU $MA $CNC $S $GILD $MTCH $AMD $BAC $GE $FB $INTC $JNPR $SQ… https://t.co/t1DYzoF2fF
RT @trade_nut: PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
Upgrades: $TCF $TDS $CATY $UFS $IRWD $MLM $VMC $HFWA $EV $CBD $JNPR $EVTC $FCX $USM
PM Price &/or Vol Leaders (a/o8:42amEST): $HCHC $AVGR $PYDS $LITE $SFLY $TRVN $JNPR $MARA $OCLR $DPW $EVTC $W $FCAU… https://t.co/7z6hK7XR8f
#estate asset watch - gapping in price this morning - up: $AAPL $MA $LITE $HCHC $NVO $JNPR $SPOT $EVTC $V $CVS $RIO… https://t.co/SoxIflyL1K
Great MTL coming up on @TDANetwork talking $AAPL $SNAP $JNPR $CVS $YUM market structure w/@kmcpartland and tech post- $AAPL w/Kim Forrest

$INCY

RT @owermohle: Incyte is going back to proof-of-concept for key pipeline drug, slashing trials in the meantime $INCY https://t.co/5xu7Fwb6E…
$HTBX was today, tomorrow will be $EVFM Super LowFloater, only 2M freefloat watching for explosion $NVCN $EBIO… https://t.co/R9R0JYo214
$INCY earnings move -1.8% vs an expected ±8.0% move https://t.co/mGBUEg3Vsh
Most here are early birds, but some are ready for flight. $FII $FLC $FMY $GEAGY $GNGBY $GT $GTN $HMMR $HSY $HUBB… https://t.co/92GWFHNphw
RT @bradloncar: Huge week of earnings coming up. M: $AGN $NBIX T: $GILD $INCY $IRWD $MRK W: $EXEL $NVO $UTHR T: $ALNY $REGN $SAGE $SRPT F:…
RT @endpts: IDO rout: Bristol-Myers, Merck and AstraZeneca dump pivotal trials in wake of Incyte’s pivotal implosion in yet another setback…
$INCY #Incyte Corp. Dont Write Off Incyte After IDO and AdCom Flops; Healthy 1Q Jakafi Growth Supports $98 FVE: Aft… https://t.co/dujj5x2Cji
Incyte Corp Receives a Hold from Oppenheimer $INCY https://t.co/wWjEg4iW3O
Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates… https://t.co/Ka1p6eFNi1
Incyte $INCY Hits New 52-Week High and Low at $60.63 https://t.co/Dn80yiu56K
$GILD $BIIB $CELG $REGN $INCY I don't even own a PS4 but I think this is how investors feel towards the clowns runn… https://t.co/gVJ3ihaDzU
RT @SwingTraderstoc: Most here are early birds, but some are ready for flight. $FII $FLC $FMY $GEAGY $GNGBY $GT $GTN $HMMR $HSY $HUBB $HZN…
RT @crusadernz: Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates $GILD $GLPG…
RT @SA_BioTech: $INCY https://t.co/KdnhDiy3L7
a downtrend in immune-onc sector since $INCY trial failure. $CNCR chart. Probably less than five immune-onc combos… https://t.co/9Ne3f8ThXc
RT @crusadernz: Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates $GILD $GLPG…
$INCY Baker brother’s losing a fortune
Tuesday's (5/1/18) 52 week low & volume above 3-mth avg: $COMM $LL $HAIN $AYI $BUD $DISH $REGN $T $CL $IVZ $INCY $KHC $TSRO $K
RT @JohnCendpts: It's bad -- IDO rout: Bristol-Myers, Merck and AstraZeneca dump pivotal trials in wake of Incyte’s pivotal implosion in ye…
RT @BioStocks: $INCY initiated at Outperform at JMP. PT $75
$INCY initiated at Outperform at JMP. PT $75
Oppenheimer Analysts Give Incyte $INCY a $65.00 Price Target https://t.co/2oR3ruDi2T
Analysts Are Bullish on These Healthcare Stocks: INCY, OXFD $INCY https://t.co/s3jNU17lqN
Oppenheimer Analysts Give Incyte $INCY a $65.00 Price Target https://t.co/TkicOJKahX
RT @JacobPlieth: $MRK & $INCY confirmed that IDO prog has been scaled back. Some trials are continuing. Named TLR, Sting & oncolytic virus…
Incyte $INCY Given Buy Rating at Cowen https://t.co/Adl7z2K62B

$BSX

$MX, $BLMN, $AROC, $TNET, $TXRH, $IIVI, $PFGC, $SFNC, $LIVN, $PSX, $DRE, $WETF, $CCOI, $FET, $TLND, $CFR, $BSX,… https://t.co/mY1fwqQ1mQ
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $IFXY $NGBL $TEAM $ILST $BKEN $NFLX $OCSY $SQ $ABX $HBR…
$BSX Belo Sun Announces AGM Results Toronto Stock Exchange:BSX https://t.co/RGG1sIuL5u
Belo Sun Announces AGM Results $BSX https://t.co/sBPZ41gDb1
Boston Scientific $BSX Receiving Somewhat Positive Media Coverage, Analysis Finds https://t.co/nt0qHr2i9y
Boston Scientific $BSX Receiving Somewhat Positive Media Coverage, Analysis Finds https://t.co/YGmBOZmDOM
RT @arnabch01: #AI #ML #BigData #nanotech t give massive boast t #Wearabletech #Medtech #Digitalhealth $GOOG $MSFT $AAPL $INTC $GE $JNJ $MD…
$MLI $F $DLTR $BSX $SHW $KODK $HCHC $SHERF $WLB $IACG $JONE $NXPI $VIA $RSIIX $RSIVX $RPHIX $RPHYX https://t.co/CtHkTO5yGJ
$MLI $F $DLTR $BSX $SHW $KODK $HCHC $SHERF $WLB $IACG $JONE $NXPI $VIA $RSIIX $RSIVX $RPHIX $RPHYX https://t.co/IeVYWJDrXD
Boston Scientific $BSX Upgraded to “Buy” by ValuEngine https://t.co/ytAn5b84yS
Equities Analysts Issue Forecasts for Boston Scientific’s Q2 2018 Earnings $BSX https://t.co/o87idBNGCd
$Vmsi .07 $etbi .004 Bloody day in Market $DOW $NSDQ $SP $BTC $9017 $ETH 681 $XRP .85 $XLM .441 Rally for 2% o… https://t.co/nUNPcx1fdf
Brokers Set Expectations for Boston Scientific’s FY2018 Earnings $BSX https://t.co/BN5HGO6a4P
Brokers Set Expectations for Boston Scientific’s FY2018 Earnings $BSX https://t.co/h3hSy6Zemb
BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY… https://t.co/8RTufi9TZT
RT @BACTop50Cies: BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY $ECL $UNH…
RT @BACTop50Cies: BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY $ECL $UNH…

$MYL

I'm Soooo Looking Forward To Justice! Justice For Victims of Rich Defendants in America Is Too Slow! $aapl $amzn… https://t.co/Gr3QAFyi1H
My Strategic Alternatives For #Allergan 1) Fire Brent Saunders & Replace W/ Trusted Pharma Professional ( Non-Lawye… https://t.co/xUQDSj4tWY
RT @DailyStockPlays: Big Call Activity https://t.co/3AchXjbMWD … $MSFT $DB $ON $MO $WRK $CMG $ECA $MYL $SNAP $PPC $AVGO $BIDU $UAA $NKE $RT…
#Allergan Gives Adjusted Performance Net Income Guidance But Fails To Define Adjusted Performance Net Income In Mos… https://t.co/JXBXHvXv4Q
Tricky & Bold.#Allergan Shares Adjusted Performance Net Income Guidance In Non SEC Submitted Investor Presentations… https://t.co/9V2EOxHevr
Evidence The Market is Catching On To #Allergan's Tone At The Top! $aapl $amzn $agn $brk $crm $cmg $dis $esrx $ead… https://t.co/cN6XzNLNbt
FREE Booklet: Getting Started in the Share Market https://t.co/HJK8y4Zy3V $AMP $ANZ $BHP $BXB $CBA $CSL $IAG… https://t.co/gkIeKnxQUL
Current #Allergan Mgmt Gets Caught In Many Examples of Trying To Mislead & Manipulate Data Harming Patients, Invest… https://t.co/tnrTkq2M5k
The short sell volume percent for $MYL on 2018-04-30 is 40%. https://t.co/Eh9qQwgYgg $VRX 58% $LCI 71% $PFE 60% $IPXL 75%
MYANMAR METALS Ltd has secured the option for a controlling interest in the world-class Bawdwin silver/lead/zinc/co… https://t.co/FfSZHemYJL
RT @Jessica_Danelle: This is a great step for $MYL shareholders and what some have been waiting for. #Myanmar Metals got govt tick of appro…
This is a great step for $MYL shareholders and what some have been waiting for. #Myanmar Metals got govt tick of ap… https://t.co/MbWWi5AvCF
$MYL baldwin project further de-risked #ASX https://t.co/zeYRIyRAR5
$MYL @Myanmar_ASX chart as at 11am #ASX https://t.co/7HPv5OkLi8
Mylan $MYL Expected to Post Quarterly Sales of $2.78 Billion https://t.co/g2Cht7OmR2
RT @Jessica_Danelle: This is a great step for $MYL shareholders and what some have been waiting for. #Myanmar Metals got govt tick of appro…
RT @boardroom_media: MYANMAR METALS Ltd has secured the option for a controlling interest in the world-class Bawdwin silver/lead/zinc/coppe…
RT @findgreatstocks: $MYL baldwin project further de-risked #ASX https://t.co/zeYRIyRAR5
I Got an Email From Someone. Here's What They Had to Say About #Allergan 's Chairman & CEO Saunders $dis $esrx $agn… https://t.co/he518dCV8O
RT @Jessica_Danelle: This is a great step for $MYL shareholders and what some have been waiting for. #Myanmar Metals got govt tick of appro…
RT @findgreatstocks: $MYL baldwin project further de-risked #ASX https://t.co/zeYRIyRAR5
I Got an Email From Someone. Here's What They Had to Say About #Allergan 's Chairman & CEO Saunders $aapl $amzn… https://t.co/SOMIXzL2Sg
#Allergan Borrowed $709MM In Q1 After Stating in 10K "Available Cash Balances Would Be Sufficient" $aapl $amzn $agn… https://t.co/THxtw4GdOM
#Allergan CEO Shared He Knew Trustworthiness Was Top Yet Became Untrustworthy as LOSSES MOUNT! $esrx $agn $ms $gs… https://t.co/zwhY1HF0SL
#Allergan Increased Their 2018 Loss Per Share Guidance By 32% To ~(2.50)/Sh.~$850MM $dis $esrx $agn $ms $gs $wfc… https://t.co/Qjnbw5HlMk

$AME

#earnings tomorrow $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO… https://t.co/NODQ8lQFXd
@JuiceWorlddd $ame
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
#earnings tomorrow $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO… https://t.co/mCnyGeiDxE
@jessssiva $ame like wise
Wise use exuberance Juliet to learn advantages of raising Quail for eggs n meat o'er louder poultry types;) $mart t… https://t.co/vo7IeATx9c
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
RT @WarrenBuffetHQ: When you are grateful – when you can see what you have – you unlock blessings to flow in your life The Best Stock Inves…
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
RT @eWhispers: tomorrow morning's #earnings $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $…
5/2/18 Earnings before the opening bell: $DDD $ADP $ACOR $AMRN $AME $APTV $ASC $ARCC $TECH $BPMC $BG $BPMC $EXK… https://t.co/pCsyfg5EYQ
#earnings today $MA $CHK $CVS $W $S $EL $LITE $CLX $ADP $HUM $SODA $SO $GRMN $NCLH $TAP $ZTS $WYN $HRS $CRTO $HFC… https://t.co/QNVtweUsVB
RT @RafaelNorma: @BrianPaulStuart @realDonaldTrump #The_world according to @realdonaldtrump #El_Mundo, #de_acuerdo_con @realdonaldtrump.. #…
RT @RafaelNorma: @BrianPaulStuart @realDonaldTrump #The_world according to @realdonaldtrump #El_Mundo, #de_acuerdo_con @realdonaldtrump.. #…
@BrianPaulStuart @realDonaldTrump #The_world according to @realdonaldtrump #El_Mundo, #de_acuerdo_con… https://t.co/g6KA2ULumt
$AME AMETEK Announces Record First Quarter Results And Raises 2018 Guidance From our Stock News Alerts App
The most accurate $AME estimate is from mauaba, beating 6 other analysts and the Wall Street Consensus - https://t.co/nZ6dDKQC0F
$AME beats the Estimize EPS Consensus by 5c and the Estimize Revenue Consensus by $23.71M - https://t.co/04Yy18wXx9
$AME reports FQ1 earnings of 78c EPS and $1.17B Revs - https://t.co/Ywv4IkwC14
$AME AMETEK Acquires SoundCom Systems From our Stock News Alerts App
Ametek beats by $0.06, beats on revenue https://t.co/L45PBgkqAP #premarket $AME
@HIllaryClinton NO QUISO VENIR A #SU_TRASPATIO.... por su desprecio hacia #México perdió una oportunidad para acab… https://t.co/k3qGjnZSPq
$AME Listen to Q1 2018 AMTEK, Inc. Earnings Call live at 08:30 AM, ondemand after - https://t.co/mRWPgv8MWf

$WY

$KN Market Feed - Notable Stock Market and Options Activity https://t.co/QpT2e7iMPr $AAT $TVIX $CCI $WY $XOM $PFE $MRK $VZ $TPR $DWDP
$AMT $CCI $WY $XOM $PFE $MRK $VZ $TPR $DWDP $KN $WRK $BABA $C $CBRE $HD $MPC $PH $WHR $TJX $T $JNJ Largest MOC buys https://t.co/sir2AvVgId
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $TAP $NGD $AGNC $K $CEGX $I $ADI $LEN $AR $D $ADM $HES…
RT @WarrenBuffetHQ: Buy a stock the way you would buy a house. Understand and like it such that you’d be content to own it in the absence o…
@DividendMaster $WY distributions have been long term cap gains.
Largest $Notional Buy On Close Order Imbalances $AMT $CCI $WY $XOM $PFE $MRK $VZ $TPR $DWDP $KN https://t.co/V7Aciy2vFa
Investors Buy Weyerhaeuser $WY on Weakness https://t.co/NpQ7rE9Etz
Weyerhaeuser $WY Price Target Raised to $42.00 at Citigroup https://t.co/Qzpl469npF
$AMT $AVB $CCI $DLR $ELS $EQIX $EQR $FREL $PLD $PSA $SPG $SUI $UMH $VNQ $WHLR $WY https://t.co/pkELiOVPFf

$A

crissse #TheTruth #Verite se fait bai$é dans $a cour de QQQQ #Étatfort QQQQQ #quebecoriginal… https://t.co/C5FY4T6hRZ
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
$ATE $ONE $SALT $AT $A $KEY $CUBS $ARE $EXAM $HE $EFF $LOW
RT @mickgelligen: @sunriseon7 could Kochie explain why petrol prices are high given oil price high $A
EZ shares flat (mostly closed), US shares +0.3% (but up from -0.9%) led higher by tech stocks (Apple beat after the… https://t.co/SGYBxIyfqC
CHP'nin yaptigina $a$irmiyorum. CHP'nin yaptigina $a$iranlara $a$iriyorum. Sizde hic mi goz yok izan yok.
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
$DO $MS $AIR $FOR $A $SUN $YUM! $I $AM $TEN $CUBS $TEN $CUBS $AGO
$A falls to an almost one-year low https://t.co/JjNJ8ndShq
$I $AM $OUT $A $POST $MET $MR $EMO $HE $FLY $EMO
US extends tariff exemptions; Telethon $36.4m; Live exports; CBA pay cuts; China tourism warning; Austal; Power Led… https://t.co/ZJQ6kGMPSP
$A falls to an almost one-year low: #wapol #auspol https://t.co/2lhnzZMKZL
$A falls to an almost one-year low https://t.co/RR6KmNNbQ9 #BusinessNews #AustraliaNews
$HI! $I $AM $AT $A $CAT $MS $AIR $AT $A $GUT
$PAY $A $COT $AT $SEAS $IM $TOO $EMO $HE $CRY $TWO $SEAS $AGO
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
RT @Alpha_Token: $A is now trackable on @BlockfolioApp. Great work team! https://t.co/KSyT9RaTAT for more on the project...in case you have…
RT @Alpha_Token: Thank you everyone involved in our active #Trader #Airdrop. To participate: Trade $A on https://t.co/QdVYNN2OvW Then…
$IT $ACE $ONE $OUT $A $PAR $MR $ESE $ATE $ONE $EXAM $AT $A $TV
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $TRSI $A $CENX $DVMT $VOYA $SGSI $FNSR $CBI $ZEN $NYT $…
RT @FZucchi: Thru April, new buyback announcements were tracking almost exactly at last year's pace - $209B ('17 total = $625B). Today's $A…
$SWAY $MR $OAK $AT $A $STAR $MS $BEN $I $ACE $AXE
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
@ElaiineFtNoni SEGUN MIS CALCULOS NONI ESTABA EN YOUTUBE Y VIO QUE ESE TITULO LLAMO ESAS VISITAS Y DECIDIO HACERLO… https://t.co/KnuQYhZrEd
RT @FZucchi: Thru April, new buyback announcements were tracking almost exactly at last year's pace - $209B ('17 total = $625B). Today's $A…
RT @FZucchi: Thru April, new buyback announcements were tracking almost exactly at last year's pace - $209B ('17 total = $625B). Today's $A…
$CUBS $ARE $EMO $I $HUM $FUN $BAM! $I $FLOW $OUT $A $SALT
$OUT $CUBS $BORN $OUT $A $RICE $SEAS $ARE $MY $GLOB $AT $DATA
Critical Analysis: Smith $A.O. $AOS vs. Whirlpool $WHR https://t.co/sw4Q1WoB9h
Head to Head Contrast: Smith $A.O. $AOS vs. Whirlpool $WHR https://t.co/kv83iHU0Pc
RT @FZucchi: Thru April, new buyback announcements were tracking almost exactly at last year's pace - $209B ('17 total = $625B). Today's $A…
RT @Alpha_Token: $A is now trackable on @BlockfolioApp. Great work team! https://t.co/KSyT9RaTAT for more on the project...in case you have…
Head to Head Contrast: Smith $A.O. $AOS vs. Whirlpool $WHR https://t.co/ollZfHGHNJ
RT @1000btc_club: (For Holders only) Prediction in 2018: @TomoChainANN $TOMO $18 @ZeepinChain $ZPT $1.5 @Hacken_io $HKN $40 @ArcBlock_io $A…
$OUT $A $GLOP $I $FLOW $TOO $HD $CUBS $ARE $MS $KATE
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
$EAT $TEN $DATA $AT $A $DECK $I $AM $MR $LEO $IM $MR $CAT $OUT $MEN
$OUT $A $LEAF $BAM! $PAY $TEN
$A $WAGE $HI! $MMM! $IM $ALL $MEN $AGO
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
#Apple qui distribue 100 milliards $à ses actionnaires mais qui ne cherche pas à améliorer les conditions de travai… https://t.co/ObixG37ZeI
Why would anyone ask this php code question in a job interview https://t.co/obPGvMVGyR #PHP I'm gonna have a litt… https://t.co/BYOLLgmM0R
$DO $FOR $A $PEN $I $AM $OUT $ADS $EAT $AT $A $COG
Zacks: Brokerages Expect Smith $A.O. Co. $AOS to Post $0.62 EPS https://t.co/UgZhZgjySP
$0.62 EPS Expected for Smith $A.O. Co. $AOS This Quarter https://t.co/fl8c7VVCTQ
Smith $A.O. Co. $AOS to Post Q2 2018 Earnings of $0.59 Per Share, William Blair Forecasts https://t.co/PdDduTzXaa
$IT $EFF $EMO $MET $MR $EROS $OUT $A $TIME $FOR $ADS
$IT $FLY $MS $MAC $OUT $HUBS $A $BLT $SEAS $ARE $AFT
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
@civardagezerali Çilemizi s2m dicem olmicak zakkumcu dr u göçürdüler Küba 1 $a aşı satıyor şimdi engellesinler bakalım yiyorsa
preopen: In a topological space, a subset A is called preopen if $A\subset\mathrm{intcl}A$. https://t.co/JyEbhoHnOx
Analysts Set Expectations for Smith $A.O. Co.’s FY2020 Earnings $AOS https://t.co/wWGH33ACVe
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
$a = NULL; echo $a Warning!!
function dilutealphapixel($im, $x, $y, $a){ imagealphablending($im, false); imagesavealpha($im, true); $rgb = image… https://t.co/4sDfMIeN1i
RT @Alpha_Token: #Telegram #Contest! Want your chance to win over 200 $A? Join https://t.co/rLZzUrV9pb and submit your #ERC20 address for…
$YUM! $HE $ACE $MS $ACRE $HUBS $ARE $EMO $OUT $A $LOCK
RT @rimisback: I couldn't have said this better.... @Yasch22 post on BlackBerry vs Avaya and the $40M BlackBerry IP revenue for Q12019 $A…
$IM $MY $BOOT $FOR $DATA $MR $RICE $HUM $TEN $FOR $A $FUR

$HES

$HES $XOM Exxon Defends Guyana Deal as Oil Giant Pushes for Quick Output via https://t.co/jURZDymPXI
$HES the bull pattern is confirmed & a BUY signal is issued @ https://t.co/6VvdEt3NS0. Buy Level: 57.4650 Target: 60.3382
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $TAP $NGD $AGNC $K $CEGX $I $ADI $LEN $AR $D $ADM $HES…
RT @WarrenBuffetHQ: Buy a stock the way you would buy a house. Understand and like it such that you’d be content to own it in the absence o…
Brokers Issue Forecasts for Hess Co.’s Q2 2018 Earnings $HES https://t.co/Cm6dZ8lIfW
Hess Co. $HES Sees Significant Increase in Short Interest https://t.co/sbgqzGK1fR
FY2019 Earnings Estimate for Hess Co. $HES Issued By Capital One https://t.co/Lh7hxBp22N
Hess $HES Upgraded by ValuEngine to “Buy” https://t.co/Ea4ZLpRfC1

$XRX

Head-To-Head Contrast: Xerox $XRX vs. Its Peers https://t.co/fz0LtykmeW
Contrasting Xerox $XRX and Its Rivals https://t.co/90dPWAveAa
Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>… https://t.co/MdU9XiPIHf
#HotStocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>>… https://t.co/80j3gm6czV
#HotStocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>>… https://t.co/xVLTQ8kuth
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $SM $IONS $JBLU $LIGA $ECEZ $GG $ENB $DDR $ANF $CPE $XR…
RT @WarrenBuffetHQ: Calling someone who trades actively in the market an investor is like calling someone who repeatedly engages in one-nig…
#trading #investing #stocks $PVTL $SPOT $DBX $TOUR $SSYS $SLDB $MOMO $PAGS $CASA $KBH $ATVI $CAVM $MDB $TSS $FB… https://t.co/i6YLOCMTAI
.@Xerox CEO Steps Down as Company Reviews Fujifilm Deal: https://t.co/LRyIEIkbmh $XRX #CorporateGovernance https://t.co/8xON0w2mua
.@Xerox CEO Steps Down as Company Reviews Fujifilm Deal: https://t.co/8GyoU9IeZI $XRX https://t.co/ql6C3PTnPC
$XRX needs more of a shake up that just one exec. “Xerox CEO Steps Down as Company Reviews Fujifilm Deal” https://t.co/3uzp4Cm6bm
$XRX https://t.co/pXyGGckPtV
$XRX @CarlIcahn1 https://t.co/V0UtjsUYPY
Activist investors @Carl_C_Icahn & Darwin Deason manage to unseat Xerox's CEO in fight over $XRX merger w/ Japan's… https://t.co/n5mgiGVPoJ
@CNBCnow and I thought value investing was as dead as Benjamin Graham! It's nice to see $XRX have some life to it afterall!
Xerox CEO Jacobson to resign in deal with Icahn, activist shareholders https://t.co/5vSw3zllv4 $XRX $IEP
$XRX Xerox CEO to Resign After Activist Pressure on Fujifilm Deal via https://t.co/jURZDymPXI
$XRX #NYSE #Trading Technical Outlook for Week 30 Apr - NEW LOOK Hot #Stocks Video Analysis with Predictive Indica… https://t.co/GkcL3PfFlC
Xerox CEO Jacobson agrees to step down in settlement of shareholder lawsuit: court filing #xerox $XRX https://t.co/agist3WTON
RT @MichaelNovinson: BREAKING: .@Xerox CEO Jacobson, Six Board Members Out In Deal To Appease Activist Shareholder @Carl_C_Icahn $XRX @CRN…
BREAKING: .@Xerox CEO Jacobson, Six Board Members Out In Deal To Appease Activist Shareholder @Carl_C_Icahn $XRX… https://t.co/CGfKk6FZvQ
RT @jonathanmaietta: .@Xerox CEO Steps Down as Company Reviews Fujifilm Deal: https://t.co/LRyIEIkbmh $XRX #CorporateGovernance https://t.…
HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/LqX0PCsORz… https://t.co/0qGkvzKAdi
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @ReutersBiz: Xerox CEO and several board members quit to settle a suit with shareholders over Fujifilm deal https://t.co/eD3sDTP1fa by @…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Xerox CEO and several board members quit to settle a suit with shareholders over Fujifilm deal… https://t.co/F0sa4wv6FR
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/cUT7ktyZwZ
Xerox's deal to merge with Fujifilm is now gasping for air as Xerox, stung by a judge's opinion, decides to overhau… https://t.co/Hnz2H3Oyjb
$XRX $32.29 USD +0.84 (2.67% - News Out on Xerox https://t.co/jj7Ng0jXMz
Outcome was one we had outlined in CEORater #podcast episode 157: https://t.co/HV99LHRft5 $XRX #xerox https://t.co/gwM1wg52nC
New @Xerox CEO John Visentin: https://t.co/ZTxs6xPQSv $XRX #xerox #CorporateGovernance #TechnologyAcquisitions… https://t.co/YKKyn1pnzM
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/Vx6yUnTkp1
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/7GtYoLkXAF
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Fujifilm files objection against Xerox settlement https://t.co/TtWH0zpo8x $FUJIY $XRX $FUJIY
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Icahn and Deason oust Xerox CEO; deal with Fujifilm at risk #xerox $XRX https://t.co/tepAkzTJrR
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/Y9JBNIDYEa
$CEO $XRX The Wall Street Journal: Xerox CEO Jeff Jacobson resigns amid Fujifilm buyout furor https://t.co/O0FmI0gfk0
$CEO $XRX Xerox CEO quits in settlement with shareholders over Fujifilm deal https://t.co/aPRbkTJQ5Z
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/evXIOCnXuI
REUTERS reports Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings de… https://t.co/p7eqBdwJvA
RT @Reuters: Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal https://t.co/oL7K8kIihv…
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/ZJZu2HoKXP
Ep.160: @Xerox Part II - A Sale Process Coming? https://t.co/80hltwP7oN $XRX $IBM $HP $INFY $CTSH $WIT $GD $SAIC $DXC #xerox
Head to Head Contrast: Xerox $XRX versus The Competition https://t.co/AjKQgKXgq0
Analyzing Xerox $XRX and Its Competitors https://t.co/zsb59WEJ2E
Xerox boss and executives ousted in Fujifilm merger row #xerox $XRX https://t.co/yY0Yi9N9B6
Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>… https://t.co/5GPeDTWVTH
RT @pbrat40plus: Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>> https://t.co/LaJu8RUj7I #N…
$AAPL #APPLE $AMZN $AVGO $FB $GE $MSFT $NVDA $PG $QCOM $QQQ $TXN $VOO $XOM $XRX https://t.co/XAXmRYV4mR
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
$XRX New Form 8-K for Xerox Corporation From our Stock News Alerts App
$XRX: Xerox reaches agreement with Carl Icahn and Darwin Deason; settles pending proxy contest and litigation; no... https://t.co/j5eJ3kstMK
$XRX Xerox Corporation SEC Filing: Form 8-K https://t.co/8chp1IRBhg
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
Xerox Corp. $XRX Removed from JPMorgan Focus List, 'We Expect Solid 1Q Results But Everything Else ... https://t.co/J8YJu69iV5
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
RT @ReutersBiz: Xerox CEO quits in settlement with shareholders over Fujifilm deal https://t.co/3vPvgqdDoG by @ismail___s @Subrat_Patnaik $…
RT @theflynews: Xerox CEO to resign to resolve proxy contst with Icahn, Darwin Deason $XRX $FUJIY https://t.co/EoRs4kMGsr
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
RT @ReutersBiz: Xerox CEO quits in settlement with shareholders over Fujifilm deal https://t.co/3vPvgqdDoG by @ismail___s @Subrat_Patnaik $…
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fuj… https://t.co/3E2dTdhv4M
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
Xerox CEO quits in settlement with shareholders over Fujifilm deal https://t.co/3vPvgqdDoG by @ismail___s… https://t.co/4ipXbfDdwZ
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
RT @Reuters: Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdi…
Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fuj… https://t.co/DrBN1HJAsG
Xerox Ousts CEO In Deal With Icahn $XRX https://t.co/yPnuJmjLZo https://t.co/fP8XBhWMeh
RT @theflynews: Xerox CEO to resign to resolve proxy contst with Icahn, Darwin Deason $XRX $FUJIY https://t.co/EoRs4kMGsr
Xerox CEO to resign to resolve proxy contst with Icahn, Darwin Deason $XRX $FUJIY https://t.co/EoRs4kMGsr
$CEO $XRX Icahn and Deason oust Xerox CEO; deal with Fujifilm at risk https://t.co/1TmG1j1IUH
HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/pJd7FAN8Pu… https://t.co/1BvzM5cEG9
Apple $AAPL, Tesla $TSLA, Federal Reserve, Xerox $XRX and Snap $SNAP - 5 Things You Must Know https://t.co/9CUDsn5r2c
@AlisonFrankel @kslaw @blbglaw Let’s also talk about Paul, Weiss advice to $XRX in pushing this deal through
$FB, $SNAP, $AAPL, $TSLA, $NFLX, $XRX, $F https://t.co/MMRiwZyer5
Scutify Pre-Market. Apple Beats expectations, Snap Shares Sink As Redesign Weighs On Results. #Earnings #FOMC… https://t.co/VGfDv1IW6M
Xerox $XRX Scheduled to Post Quarterly Earnings on Thursday https://t.co/X4DIlFWuU6
RT @theflynews: Xerox CEO to resign to resolve proxy contst with Icahn, Darwin Deason $XRX $FUJIY https://t.co/EoRs4kMGsr
$XRX: New SEC Filing for XRX: Form 8-K (No. 0001193125-18-147461): https://t.co/OoYM7tKVpm
Xerox CEO and several board members to step down to settle a suit brought by activist shareholders over Japan’s Fuj… https://t.co/WjLYj1ksl6
Xerox CEO quits to settle a suit brought by activist shareholders over Japan’s Fujifilm Holdings deal… https://t.co/EQg5buXpqx
RT @pbrat40plus: HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/pJd7FAN8Pu #mtbanal…
RT @trade_nut: PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
BREAKING - @FujifilmUS To File Objection In Court Against @Xerox Settlement With Activist Investors @Carl_C_Icahn,… https://t.co/nnIjxiwKlE
RT @TheDealNewsroom: Xerox $XRX Ousts CEO In Deal With Icahn https://t.co/Cq7YoawKo7
Xerox $XRX Ousts CEO In Deal With Icahn https://t.co/Cq7YoawKo7
RT @OpenOutcrier: $XRX (+0.5% pre) Icahn Ousts Xerox Boss, Puts $6.1 Billion Fujifilm Deal in Limbo - BBG https://t.co/uV9rp6lvmg
$XRX (+0.5% pre) Icahn Ousts Xerox Boss, Puts $6.1 Billion Fujifilm Deal in Limbo - BBG https://t.co/uV9rp6lvmg

$AA

Stocks to watch. $AAPL $GOOGL $INTC $SHOP $I $AKAO $DBX $PYPL $AKAO $FB $BLUE $AA $LABU $XBI $NTNX $TXN $MS $ORCL $PENN $PI $SPOT $QQQ $SPY
$AA $AWF $BGX $BKH $BRX $BXMT $CLNS $D $DFP $DIA $DOC $DSL $DSLV $EMD $EPR $EVV $FAX $FEO $FLC $FRA $GE $GLD $GOV https://t.co/Eeqmb0v9p4
Today's earnings/swing recap part 1 $COHR $BABA $ATVI $SHOP $GRUB $STX $SPY $AA visit us at https://t.co/JKq9fYdRfn… https://t.co/PlDnskMkVM
RT @DavidGZeiler: #Apple beats on #earnings, $2.73 vs. $2.68 and hits revenue on target with $61.1 billion. My musings earlier today on $AA…
https://t.co/uAcamNRUPt alerted $AVXL +74% https://t.co/ptG4263qkj See Track Record $CAM $KMI $MAR $INTC $C $AA $GM… https://t.co/WtjUuA1P2Y
RT @DavidGZeiler: #Apple beats on #earnings, $2.73 vs. $2.68 and hits revenue on target with $61.1 billion. My musings earlier today on $AA…

$GILD

Gilead announced a partnership with Alphabet’s Verily Life Science. The biotech start-up will run tests on white bl… https://t.co/3VzDGQ69Oq
RT @MaxJacobsEdison: HCV sales for $GILD are down 59% year over year and 30% sequentially. When did big biotech earnings get so depressing…
RT @BiotechRadar: Galapagos $GLPG / Gilead $GILD: filgotinib-related catalysts Q1 2018 update, slight shifts https://t.co/4g89fCna3B
Gilead Sciences $GILD Releases Earnings Results, Misses Expectations By $0.19 EPS https://t.co/LyYFTl35S6
Gilead Sciences $GILD Announces Earnings Results, Misses Expectations By $0.19 EPS https://t.co/ecPLdoCMZ0
RT @matthewherper: $GILD seeing good reimbursement for Yescarta in both commercial and Medicare populations.
2013 interview question with Lori M. Waldron Member of Life Sciences practice group responding to a troubling BigPh… https://t.co/kxh6CYi0bf
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @JohnCendpts: #3 Gilead joins the lineup of big biopharma partners to ally with Verily — this time focused on immunology $GILD https://t…
So let’s see now $mrk $pfe & $gild all have declining revenue, and All also have hardly any pipeline/ R an D left.… https://t.co/Nl0E3xrVfo
$GILD $1.046B HCV is better than Mavyret ever did.
$GILD from block buster to block duster . ..falling sales and they bought $KITE to do what
Gilead Q1 revenue, profit miss estimates, as hepatitis C drug sales more than halve https://t.co/7fEYHDegyL $GILD #pharma
RT @RobertLKruse: "Based on current HCV management practices, it will take 4-6 years to treat the majority of patients aware of their disea…
"Based on current HCV management practices, it will take 4-6 years to treat the majority of patients aware of their… https://t.co/Gs1VtLG2gw
$GILD https://t.co/CXVPXAVBjw
$GILD never fails to disappoint.. misses expectations. #figureitout $IBB $XBI #investing #biotech #healthcare
Gilead topples as its hepatitis C drug franchise continues to crumble $GILD https://t.co/Jtp7N5pMUA
@Lblegend33 Market share... everyone saw this coming except $gild mgmt apparently and they didn’t set themselves up to overcome this
Incredible chart. That said, still so many patients out there remain to be cured of #HCV and with a huge market.… https://t.co/2qETaSsncO
RT @TradeTexasBig: $GILD 68.. buyzone 64 to 66.. as long as they have cash..
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
JPM got it right $GILD https://t.co/gFqqkYGDRR
$gild=RIP
$GILD 68.. buyzone 64 to 66.. as long as they have cash..
@ScripMandy Same old story. $GILD said the same before buying $KITE. "We're going to stick to our NASH pipeline" and then it came the BO
RT @ai_autonomous: Perelman AI Algorithm Crashes Gilead Sciences on Multi-Billion Profit $GILD #biotech #earnings #AI #perelman https://t.c…
RT @ai_autonomous: Perelman AI Algorithm Crashes Gilead Sciences on Multi-Billion Profit $GILD #biotech #earnings #AI #perelman https://t.c…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
Perelman AI Algorithm Crashes Gilead Sciences on Multi-Billion Profit $GILD #biotech #earnings #AI #perelman… https://t.co/g3WHUTn1Bx
RT @CaesarBiotech: $GILD Confirmation on Q1 slides: Gilead hbv pipeline is on attrition phase despite Milligan said last year that their ma…
That said, $GILD popped after the KITE pharma acquisition but then declined thereafter - as if the acquisition was… https://t.co/UYRxXT66q9
Gilead Sciences $GILD Announces Earnings Results, Misses Expectations By $0.19 EPS https://t.co/DwbKSIj60b
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
AI Perelman Algorithm Crashes Gilead Sciences on Multi-Billion Profit $GILD: https://t.co/kPrnUAaHkZ via @YouTube
$GILD was usually pitched with "buy it for the HIV business - get HCV business for free". With Harvoni sales in %74… https://t.co/yEu5sYAYOC
My second "Am I reading this right?" of the day: $GILD has $32B in cash & cash equivalents? Is it time to go shopping?
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @FayCortez: Small bright spot for $GILD on Yescarta - blowing past the $16 million estimate from analysts with a $40 million first full…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @EpiscopalianTra: $GILD At this rate, this company will be an acquiree, not acquirer. I'd go in at around $63
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
$GILD At this rate, this company will be an acquiree, not acquirer. I'd go in at around $63
$GILD stock down -5.60% after hours, stock continues to slide since last year Q1. See our past data recap https://t.co/2HGBRABCBQ
$GILD Robin Washington keeps saying “we’re comfortable with where we are” but investors clearly not. Down 5.6% after hours at $68.50.
$GILD seeing good reimbursement for Yescarta in both commercial and Medicare populations.
Unicorn Bay rating for $GILD is 2.79 out of 5. https://t.co/jD70zGcNYE
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to t… https://t.co/NVXoH6Xdm5
$GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opport… https://t.co/nbgqZlYKzL
$Gild earnings https://t.co/JFVnt6KXib
RT @FayCortez: Small bright spot for $GILD on Yescarta - blowing past the $16 million estimate from analysts with a $40 million first full…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
The stock market is always ready, are you? $AAPL $SNAP $MTCH $GILD https://t.co/BeLiyDZQtp https://t.co/debWlHtsTZ
@pawcio2009 Go nuts xbi doesn’t matter and most of ours in xbi. who cares about ibb big cap Pharm and $gild
$GILD Down 4.9% in After Hours Trading. Gilead Sciences Valuation, Profitability, and Dividend Safety Scores. Stock… https://t.co/cZVAXsaSTl
#3 Gilead joins the lineup of big biopharma partners to ally with Verily — this time focused on immunology $GILD https://t.co/austsLDo3T
RT @AndyBiotech: $GILD Yescarta Q1 sales $40M beat consensus of $16M (though buyside expectation higher after $NVS Kymriah number and WSJ s…
Gilead $gild stabilizing as we work through the beginning of the Q&A portion on the call. Will be interested to see… https://t.co/0WeakrbKL7
$GILD revenues in free fall adapt or become obsolete https://t.co/19vvaTnqbY
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @FayCortez: Small bright spot for $GILD on Yescarta - blowing past the $16 million estimate from analysts with a $40 million first full…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @Lblegend33: So let’s see now $mrk $pfe & $gild all have declining revenue, and All also have hardly any pipeline/ R an D left. Yet they…
RT @eWhispers: #earnings after the close $AAPL $SNAP $GILD $COHR $TMUS $PAYC $DVN $SU $WATT $APC $BGFV $JNPR $MDLZ $ALL $FTR $WU $MDLP $CH…
Access tools built by 10% traders for 10% traders $MTCH $GILD $AAPL $SNAP https://t.co/BeLiyDZQtp https://t.co/HGy1GvSgwo
Post Mkt Gappers/Crappers $NANO $CRAY $SFLY $ZEN $EVTC $AAPL $SNAP $YUMC $GILD $PAYC $SKT $KR Try our FREE chat… https://t.co/g0P8eKAadM
Can $NVO, $AZN and $CELG change the tone on a generally bleak Q1 earnings period? https://t.co/zaWw0JlIKr $GILD $MRK $PFE
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
$sgmo did $gild confirm anywhere that they did purchase 50 million$ of $sgmo shares on $sgmo BS stock offering ?? asking ??
$GILD 04-May-18 ATM Implied Vol Jumps +11.3% to 51.7. Straddle Implies a Move of ±4.5% https://t.co/ZQOfhHMvOD
I’ve been describing $GILD HCV cure as revenue cliff for years since incidence was tiny and prevalence would declin… https://t.co/rkdHDDhac5
@TradeWithNinja $GILD missed
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
▶ Stock Selection By Using AI & Machine Learning: Top 10 Stocks For May + Top 20 Tech Stocks...… https://t.co/QtYzPRCOZq
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymr… https://t.co/tBPa10HfTr
$GILD what a disaster
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @sesiegler: @cells_nnm @bradloncar @JacobPlieth @matthewherper @BLLPHD @AndyBiotech @MaverickNY Also, they filed a NTAP for FY2019. @CM…
$GILD Q1 total product sales -22% YoY HCV sales -59% YoY HIV + HBV sales +2% YoY other product sales +17% YoY
@cells_nnm @bradloncar @JacobPlieth @matthewherper @BLLPHD @AndyBiotech @MaverickNY Also, they filed a NTAP for FY2… https://t.co/o2coerlbxZ
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
After Hours Gainers / Losers (05/01/2018) $SIGA $CYH $SFLY $ENPH $FTR $SNAP $YUMC $LPI $SKT $GILD https://t.co/9jnlypbI5r
Stocks making the biggest moves after hours: $SNAP $AAPL $GILD Snap, Apple, Gilead & more - https://t.co/MNNaxmU3rr
Gilead Sciences $GILD Announces Quarterly Earnings Results https://t.co/9TaTQ0FOnm
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
I hear the nurse was a distraught $GILD shareholder. https://t.co/T2qTUcir0y
Not the best timing for $GILD just as they finish explaining how Yescarta launch is going well and as they planned… https://t.co/IXa670s7S3
Nice call. $GILD https://t.co/G9kXo2mUSZ
Gilead Sciences $GILD Posts Quarterly Earnings Results, Misses Estimates By $0.19 EPS https://t.co/d0T6Suavrh
RT @AndyBiotech: $GILD Yescarta Q1 sales $40M beat consensus of $16M (though buyside expectation higher after $NVS Kymriah number and WSJ s…
@cells_nnm @bradloncar @JacobPlieth @matthewherper @BLLPHD @AndyBiotech @MaverickNY There’s competition now for thi… https://t.co/fFgBENGit8
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @JohnCendpts: #3 Gilead joins the lineup of big biopharma partners to ally with Verily — this time focused on immunology $GILD https://t…
RT @7LadyQ: $GILD Gilead Sciences misses by $0.19, misses on revenue Gilead Sciences (NASDAQ:GILD): Q1 EPS of $1.48 misses by $0.19. Revenu…
$GILD slide from Aug 2017 vs May 2018 (h/t: @MaxJacobsEdison) Their HCV trend never changed. It keeps.going.down.… https://t.co/twko2HFdRc
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
ICYMI. $BLUE $GILD https://t.co/SRmF829Hwm
$GILD Yescarta revs went from $7M in Q4 2017 to $40M in Q1 2018 - a 500% jump QoQ. Novartis Kymriah only $12M.
After Hours Movers: $SFLY $CRAY $ACTG $ZEN $BGFV $JNPR $AAPL $SNAP $GILD https://t.co/8mrT5SACLU
Weekly Stock Market Review: Top 10 Stock Picks For May: https://t.co/6I1fM213GR $SPY $AAPL $AMZN $MSFT $AMD… https://t.co/Crvpc5hJK4
@zbiotech @adamfeuerstein Approval of Yescarta competitor ( $NVS 's Kymriah) for r/r B-Cell Lymphoma is good news f… https://t.co/VfWN8815I8
HCV sales ex-US have *always* been more competitive for $GILD. Mgmt thinks pricing and share will stabilize in 1-2… https://t.co/Hd9poAmFUz
$GILD: Gilead Topples As Its Hepatitis C Drug Franchise Continues To Crumble: https://t.co/X1DKSAD6Cn
RT @FZucchi: @JPM63887712 They are spending $12B/yr in R&D as it is; that's just shy of what $GILD $AMGN & $MRK spend...combined...and they…
@StockTwits Trending via @Stocks_Live #stocks #stockmarket $AAPL $SNAP $GILD $MTCH $I $WATT $SHOP $MA $BSTI $TMUS… https://t.co/6qZCYWjC8m
Jim Cramer Mad Money Lightning Round https://t.co/iCW9mIHGyw $AMAT $JEC $GERN $REGN $GILD $NVDA $CGNX $BOX $EDIT $CELG $GT @jimcramer @cnbc
Gilead Sciences $GILD settled +0.4% at $72.56. With a sig' EPS/rev' miss, as at 7.10pm EST, the stock is -5.7% at $… https://t.co/IQvvDCshgE
RT @bradloncar: Huge week of earnings coming up. M: $AGN $NBIX T: $GILD $INCY $IRWD $MRK W: $EXEL $NVO $UTHR T: $ALNY $REGN $SAGE $SRPT F:…
$TEVA settled +4.1% at $18.71, above the 200/50dmas. Further, the m/t bearish trend from 2015 concluded today. Earn… https://t.co/Nn8bcA74v5
@golf_stock_life If they don’t beat, PPS will get crushed like $GILD (who for some reason decides not to talk about… https://t.co/NvP8iMNKag
@CGrantWSJ Down goes @jimcramer 's charitable trust and prolly his own shill account. $GILD BTW, throw out a posi… https://t.co/YHEVlNGxRG
$GILD announced a 0.57 dividend. Annual Yld is 3.1%. GILD raised its dividend 3 times in 3 yrs. https://t.co/swXYzZECu8
AbbVie $ABBV settled +5.7% at $102.07, as the company is seeking to buy $7.5bn of its stock back. The stock is chal… https://t.co/s5Wo2vfWcG
RT @Jdalexander64: $GILD press release - only $SGMO Oncology and Cell Therapy Programs Announced a worldwide collaboration with Sangamo Th…
@zipjet Yes My expectation was that a good part of the cash generated would be used for M&A. $GILD was too timid with a poor strategic view
▶ Stock Selection By Using #AI & Machine Learning:Top 10 Stocks For May + Top 20 Tech Stocks...… https://t.co/01ETG9vuvm
Three huge mistakes $GILD has made. 1) Curing HCV 2) Stock Buybacks 3) Curing HCV
RT @TradersFish: $GILD stock down -5.60% after hours, stock continues to slide since last year Q1. See our past data recap https://t.co/2HG…
Gilead Sciences $GILD Posts Quarterly Earnings Results, Misses Estimates By $0.19 EPS https://t.co/zp6PA8WSia
$SNAP ohhhhhhhh #SNAP ... (Also $YUMC $GILD $SKT $PAYC $LPI $COHR etc.. ready for some lucrative SHORTING tomorrow!… https://t.co/KAGTQZoPAM
@DewDiligence It will be fun to watch when the $ENTA HepC party ends. Like $GILD, it ends. When it does, will $ENTA… https://t.co/4VzMOsS7ni
STOP trading randomly, get the best opportunities and profit everyday $AAPL $SNAP $GILD $MTCH… https://t.co/gTwA2Fh7eS
RT @AndyBiotech: $GILD HCV franchise Q1 total sales $1,046M misses consensus of $1,175M US: $584M vs. $674M cons ex-US: $462M vs. $501M…
RT @FayCortez: Small bright spot for $GILD on Yescarta - blowing past the $16 million estimate from analysts with a $40 million first full…
RT @Jdalexander64: $GILD press release - only $SGMO Oncology and Cell Therapy Programs Announced a worldwide collaboration with Sangamo Th…
RT @BursatilBiotech: $GILD slide from Aug 2017 vs May 2018 (h/t: @MaxJacobsEdison) Their HCV trend never changed. It keeps.going.down. Ri…
Ugly qtr for $GILD -no two ways about it - HIV miss.. HCV miss and if the execs are comfortable bcuz of the 12 bill… https://t.co/gBzS7st4Sy
Sadly, they are well on their way, and things are likely to get worse between the new #CARTcell competition for DLB… https://t.co/SWPTgsn0nN
@JorelLaraKalel @jimcramer @CNBC At least $GILD, $CELG, and $REGN are in the same business as $GERN (unlike $ILMN,… https://t.co/rEvRxQKr31
After-Hours Stock Movers 05/01: $CRAY $CYH $AAPL Higher; $SNAP $YUMC $GILD Lower more... https://t.co/17k4roKVx8
Wednesday: $I, $AAPL, $TSLA, $TTWO, $IAC, $NOC, $GILD, $FB
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
@Sport234a Remember, years ago, when $GILD execs sarcastically asked analysts to let them know what they should buy… https://t.co/Z7GzzMUZG8
GILD pounded after the bell(-5.5%/earnings), headed for huge downside gap, will open well into fresh new '18 low te… https://t.co/hOsbJiT8Cb
@BTLipschultz @GreenMonsterah I don’t see $gild nash drug being a real threat in the nash space imho.
RT @FayCortez: Small bright spot for $GILD on Yescarta - blowing past the $16 million estimate from analysts with a $40 million first full…
$GILD Daily, weekly, and monthly support levels to get back on trend. https://t.co/6VEmzYbgdh
RT @BTLipschultz: Gilead $gild stabilizing as we work through the beginning of the Q&A portion on the call. Will be interested to see if th…
RT @AndyBiotech: $GILD HCV franchise Q1 total sales $1,046M misses consensus of $1,175M US: $584M vs. $674M cons ex-US: $462M vs. $501M…
RT @jonathanrockoff: $NVS says @US_FDA has approved Kymriah for use in adults with advanced large B-cell lymphomas, intensifying the CAR-T…
RT @JohnCendpts: #3 Gilead joins the lineup of big biopharma partners to ally with Verily — this time focused on immunology $GILD https://t…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @BursatilBiotech: $GILD slide from Aug 2017 vs May 2018 (h/t: @MaxJacobsEdison) Their HCV trend never changed. It keeps.going.down. Ri…
RT @MaxJacobsEdison: Sometimes nothing seems to go right $GILD https://t.co/6wxyleXJfu
$GIlD So when Sovaldi was approved on Dec 6 2013 share price was 73.99 How did Gilead investors get rich off Hep C… https://t.co/S3R7bHrI0v
$GILD https://t.co/kDXnBC2pOQ
$GILD https://t.co/8YmfbAzbOO
Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates… https://t.co/Ka1p6eFNi1
@YGPharmaAnalyst $GILD bruh. Yikes!! Still modeling $100+?
Beat the market with the Ideal Intensity Indicator, the only indicator you need $AAPL $SNAP $GILD $MTCH… https://t.co/3n6KazHF3b
Impressive when on company focuses on cures vs palliation and symptom control. Congrats $GILD @GileadSciences https://t.co/rYRK3uBvbl
@JekyllMorgan @timseymour Its a good acquisition, but those drugs aren't curing anyone yet... Time will tell. Same… https://t.co/E87jhefam8
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
Btw, Estimated #Earnings Per Share for $GILD is $1.92 it's 2.66% of the current price https://t.co/ITADQ4KDmZ
Get FREE Tools to manage emotions, reduce randomness, and risk mgt w/ Membership $GILD $MTCH $AAPL $SNAP… https://t.co/wf1hAQHuod
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
RT @Jdalexander64: $GILD press release - only $SGMO Oncology and Cell Therapy Programs Announced a worldwide collaboration with Sangamo Th…
RT @CompoundTrading: Post-Market Trading Report Tues May 1. $HTBX, $SNAP, $AAPL, $GILD, $APVO, $EOG, $ATHM, $CHECK, $DXY more… https://t.co…
Losing $$$ trading? Get help: ISW finds opportunities in Real-time+Live Chat $GILD $MTCH $AAPL $SNAP… https://t.co/3QYZnDMmXS
Post-Market Trading Report Tues May 1. $HTBX, $SNAP, $AAPL, $GILD, $APVO, $EOG, $ATHM, $CHECK, $DXY more…… https://t.co/AfKkcK2Ldc
Don't miss our next FREE OPTION TRADE. Sign up for our Daily Free Trades at https://t.co/v1csoSCfrS $NVDA $TSLA $GS $GILD $F $GOOGL $FB
RT @Jdalexander64: $GILD press release - only $SGMO Oncology and Cell Therapy Programs Announced a worldwide collaboration with Sangamo Th…
@Sport234a Another reminder- $GILD share repurchases were about as crappy an investment as a company could make.
RT @Jdalexander64: $SGMO wasn't my favorite pick although it went from $4 to $26, but now w 40% decline, even as signals materialize that t…
Missing out on amazing trades? ISW scanner streams right to your desktop $AAPL $SNAP $GILD $MTCH… https://t.co/PWo0FSpgRo
RT @SA_BioTech: $ABBV $AGEN $AMGN $AZN $BMY $CELG $GILD $GSK $JNJ $JUNO $LLY $MRK $NVS $PFE $REGN $SNY $EVLO https://t.co/ZbUYz8WYJI
$GILD $BIIB $CELG $REGN $INCY I don't even own a PS4 but I think this is how investors feel towards the clowns runn… https://t.co/gVJ3ihaDzU
RT @crusadernz: Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates $GILD $GLPG…
RT @crusadernz: Biotech updates 05/01: $NVS Kymriah 2nd approval $SIGA +ve adcom vote $KPTI $QURE offerings + Pipeline updates $GILD $GLPG…
$GILD i'll probably buy some down here
Tired of the stock market rollercoaster? Use it to your advantage� $GILD $MTCH $AAPL $SNAP https://t.co/BeLiyDZQtp https://t.co/t76RPGCBl1
RT @AndyBiotech: $GILD HCV franchise Q1 total sales $1,046M misses consensus of $1,175M US: $584M vs. $674M cons ex-US: $462M vs. $501M…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @MattBurns25: Weekly Stock Market Review: Top 10 Stock Picks For May: https://t.co/6I1fM213GR $SPY $AAPL $AMZN $MSFT $AMD $NVDA $ABX…
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
@BehaviorFin @Jdalexander64 8am is early for west coast companies. Last time $SGMO had an early EC they announced $GILD deal...
Not sure what to do with $GILD? Explore our #fundamental pros and cons. https://t.co/NgREtgOwQu
RT @SA_BioTech: $GILD https://t.co/kDXnBC2pOQ
$GILD back to pre $KITE levels. More acquisitions soon?
$GILD declines in after hours trading. See the latest news. https://t.co/UTiq6dErsp https://t.co/X9jn5W3MP5
Struggling with Trading? Members get full access to Training Center - FREE $AAPL $SNAP $GILD $MTCH… https://t.co/og5T2OcdR0
Gilead joins the lineup of big #biopharma partners to ally with Verily — this time focused on #immunology https://t.co/uio34iZXDg $GILD
$GILD These clowns can easily acquire other companies and expand the portfolio of offerings but NOPE
RT @NASDboy: $GILD Another one to cheer everyone up $SNAP courtesy of @bagholderquotes https://t.co/CmKVbiPPao
RT @NASDboy: $GILD just stopping by to post a few GIFS don’t mind me $SNAP https://t.co/dM8av5CF5k
End of an era $GILD https://t.co/XMZwk9Rz2w
Do you know that #Book Value for $GILD is $15.63 https://t.co/dYpmlEXDNp
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @businessinsider: A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to trea…
Not going to be a pretty day tomorrow. $GILD. < One bio that I actually like. https://t.co/GSCAZGhPZK
RT @ArabicWallSt: . هذا الاسبوع ناري باعلانات ارباحه . الاثنين - $MCD $AKS $RIG $AGN $AKAM $FDC الثلاثاء - $AAPL $SNAP $GILD $SHOP $PFE $BP…
RT @permabear_uk: Gilead Sciences $GILD settled +0.4% at $72.56. With a sig' EPS/rev' miss, as at 7.10pm EST, the stock is -5.7% at $68.40.…
Night Most Tweeted Big Caps, check out Gambiste Top 10: $GILD $ISRG $FB $AAPL $GOOGL $GOOG $AMZN https://t.co/lYp5LtitVR
Streaming alerts, Live chat, Pre-Mkt, After-Mkt, Bear scan for active traders $AAPL $SNAP $MTCH $GILD… https://t.co/LhD2HIsiAK
Wondering about risks of $GILD? The 21-day volatility is 5.5% https://t.co/YrfwPBdUuU
Btw, Estimated #Earnings Per Share for $GILD is $1.92 it's 2.65% of the current price https://t.co/ITADQ4KDmZ
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
Credit Suisse Maintains a Hold Rating on Gilead Sciences $GILD https://t.co/hMEQc0JzdU
RT @MaxPowerNGS: @BehaviorFin @Jdalexander64 8am is early for west coast companies. Last time $SGMO had an early EC they announced $GILD de…
$GILD - when you cure a disease, you better have something else in the pipeline. Time to throw in the towel ? Sell… https://t.co/I21OQfr42q
$GILD honestly their is no reason to buy or own this stock right now. Company is on the decline at a fast rate. Revenue down over 2 billion
Ideal Intensity Indicator [I^3] - Optimize Entries and Exits for more $$$ $GILD $MTCH $AAPL $SNAP… https://t.co/rVBaKREnIu
$GILD They need to acquire another company to offset the sales loses. It will take years for kite deal to pay off.
RT @permabear_uk: $TEVA settled +4.1% at $18.71, above the 200/50dmas. Further, the m/t bearish trend from 2015 concluded today. Earnings a…
$AMGN $CELG $GILD lack of growth is incredible
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
earlier: SOLD - $GILD MAY25'18 $67 PUT for $0.6721/share. In force 25 days. 15.26% annualized premium return. After… https://t.co/XRTwaAab9j
$GILD 04-May-18 ATM Implied Vol Jumps +11.3%. Straddle Implies a Move of ±4.5% https://t.co/ZQOfhHMvOD
$GILD HCV sales are collapsing... Down %59 YoY... https://t.co/fkIfuHdByd
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @BursatilBiotech: $GILD - Yescarta Sales Q1 $40M vs $16M consensus @Arie_Belldegrun , still the #1 https://t.co/HD26c8DDYl
RT @AndyBiotech: $GILD Yescarta Q1 sales $40M beat consensus of $16M (though buyside expectation higher after $NVS Kymriah number and WSJ s…
$GILD Option Order Flow Sentiment has Shifted from Bullish to Bearish. https://t.co/sD9L6tOUzF
$AAPL $GILD $SNAP After-hours buzz: SNAP, AAPL, GILD & more https://t.co/Siycp7zH3x
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
RT @GaryThomson16: ▶ Stock Selection By Using AI & Machine Learning: Top 10 Stocks For May + Top 20 Tech Stocks... https://t.co/963bxUm7ca…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
RT @MarketCurrents: Gilead Q1 top line down 22%; earnings down 43%; shares down 6% after hours https://t.co/ilnn5NTjxF $GILD
Recommendation #HOLD for $GILD with UB rating - 2.79 out of 5. https://t.co/Kn4eAPYUj7
$GILD #Buybacks https://t.co/KXHR4uj8qa
John Francis Cogan Sells 5,833 Shares of Gilead Sciences $GILD Stock https://t.co/SpDp4yABsy
RT @JacobPlieth: If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17 https://t.co/Q…
RT @bradloncar: $GILD HCV sales over time. Credit to them for curing so many patients. Now moving on and aiming to do the same for cancer…
@matthewherper And let’s also mention that all of these developments are slaps in the face if autologous cell thera… https://t.co/dtXTBJTCI0
RT @JacobPlieth: If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17 https://t.co/Q…
RT @JacobPlieth: If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17 https://t.co/Q…
If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17… https://t.co/x3GQw6COwp
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
Gilead Sciences $GILD Lowered to “Buy” at ValuEngine https://t.co/6v62rXGXWj
RT @blockcha1nx: $GILD releasing a dividend @ 60% payouts w yield >3%, on a stock w shareholders w 0 loyalty, & earnings that will go down…
$GILD releasing a dividend @ 60% payouts w yield >3%, on a stock w shareholders w 0 loyalty, & earnings that will g… https://t.co/7gskLStEP1
PharmaScrip: $ABBV Up slightly after $GILD 1Q18 release. https://t.co/JfQn0m31uZ … https://t.co/XeTlcqGrvj https://t.co/TWDSGvEWe3
RT @ScripMandy: $ABBV Up slightly after $GILD 1Q18 release. https://t.co/ssv5gYOlfo
Baird $GILD Gilead Sciences, Inc. (GILD) Ugly 1Q Raises Questions About What Trough Looks Like Lowering target pri… https://t.co/A4aj573psG
I Got an Email From Someone. Here's What They Had to Say About #Allergan 's Chairman & CEO Saunders $aapl $amzn… https://t.co/SOMIXzL2Sg
@tgtxdough Mizhou must own a lot of $gild stock, cause this thing is garbage
MIZHOU $GILD Buy, PT: $95.00, 1Q18 Call Takeaways + Spoke to Company ==> HIV Concerns Overblown, HCV Some Risk We Think
RT @JacobPlieth: If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17 https://t.co/Q…
RT @JacobPlieth: @VinayPrasadMD ...ditto for Yescarta. Label cites n=101 as denominator, not =111 (ITT in Zuma-1) $GILD https://t.co/lZ9rVy…
Gilead Sciences $GILD Lowered to “Buy” at ValuEngine https://t.co/31WsMhpZrz
RT @Lblegend33: Another bio misses on revenue $mrk. Don’t worry tho keep doing the same thing and it will miraculously change. $gild you’re…
PharmaScrip: $GILD Down 5+% after hours after reporting $5.1bn in 1Q18 revenue vs consensus of $5.4bn. EPS $1.48 b… https://t.co/55iZQsSm8p
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
@VinayPrasadMD ...ditto for Yescarta. Label cites n=101 as denominator, not =111 (ITT in Zuma-1) $GILD https://t.co/lZ9rVyyT86
RT @ScripMandy: $GILD Down 5+% after hours after reporting $5.1bn in 1Q18 revenue vs consensus of $5.4bn. EPS $1.48 below consensus of $1.6…
▶ Stock Selection By Using #AI & Machine Learning: Top 10 Stocks For May + Top 20 Tech Stocks...… https://t.co/f56BaPEBLw
RT @AndyBiotech: $GILD Yescarta Q1 sales $40M beat consensus of $16M (though buyside expectation higher after $NVS Kymriah number and WSJ s…
RT @vieiraUAE: Perelman's AI Trading Algorithm Crashes Gilead Sciences, Micron, and Snapchat $MU $SNAP $GILD #biotech #earnings #snapchat #…
RT @vieiraUAE: Perelman's AI Trading Algorithm Crashes Gilead Sciences, Micron, and Snapchat $MU $SNAP $GILD #biotech #earnings #snapchat #…
Perelman's AI Trading Algorithm Crashes Gilead Sciences, Micron, and Snapchat $MU $SNAP $GILD #biotech #earnings… https://t.co/aEjChW9KT3
$SPY $QQQ $AAPL $AMZN $FB $FPKT $FUJIY $GE $GILD $IAC $LUV $MDLZ $MRK $PFE $RUALF $SAFRY $SNAP $SSNLF $TMUS $UAA https://t.co/UxxJslrlPR
RT @SeekingAlpha: $SPY $QQQ $AAPL $AMZN $FB $FPKT $FUJIY $GE $GILD $IAC $LUV $MDLZ $MRK $PFE $RUALF $SAFRY $SNAP $SSNLF $TMUS $UAA https://…
$SPY $QQQ $AAPL $AMZN $FB $FPKT $FUJIY $GE $GILD $IAC $LUV $MDLZ $MRK $PFE $RUALF $SAFRY $SNAP $SSNLF $TMUS $UAA https://t.co/iF9chF7RlT
RT @ScripMandy: $ABBV Up slightly after $GILD 1Q18 release. https://t.co/ssv5gYOlfo
Cramer's lightning round: $AMAT $JEC $GERN $REGN $GILD $NVDA $CGNX $BOX $EDIT $CELG $GT https://t.co/TRUk9ky7Gt
Lotsa health care earnings this am: $HUM up 1.6%, $CVS up 3% and $ABC up 2.2%. Plus $GILD down 6% after reporting after hours ytd.
RT @Benzinga: 16 Stocks To Watch For May 2, 2018 https://t.co/UicGXSgIAh $AAPL $ABC $ADP $CVS $EXC $MA $PRU $HUM $SNAP $ESRX $TSLA $GILD $M…
RT @Benzinga: 16 Stocks To Watch For May 2, 2018 https://t.co/UicGXSgIAh $AAPL $ABC $ADP $CVS $EXC $MA $PRU $HUM $SNAP $ESRX $TSLA $GILD $M…
RT @Benzinga: 16 Stocks To Watch For May 2, 2018 https://t.co/UicGXSgIAh $AAPL $ABC $ADP $CVS $EXC $MA $PRU $HUM $SNAP $ESRX $TSLA $GILD $M…
RT @imriyu: @tgtxdough $GILD also have $25B in debt..
16 Stocks To Watch For May 2, 2018 https://t.co/UicGXSgIAh $AAPL $ABC $ADP $CVS $EXC $MA $PRU $HUM $SNAP $ESRX $TSLA $GILD $MET $SFLY $KHC
RT @tgtxdough: $GILD Gilead has roughly $32B in cash on the balance sheet to do deals. But free cash flow down significantly https://t.co…
RT @adamfeuerstein: $GILD ‘trough year’ looking harder to dig out from after miserable first quarter https://t.co/5gQlwcQvjh
$ABEO $ADMS $ALXN $ARRY $ATRS $BLUE $BPMC $CORT $DVAX $EXEL $GILD $GLPG $GSK $HCM $IBB $IONS $NBIX $NVCR $NVS $XBI… https://t.co/DGdIZnlxYM
Unicorn Bay rating for $GILD is 2.79 out of 5. https://t.co/jD70zGcNYE
$GILD ‘trough year’ looking harder to dig out from after miserable first quarter https://t.co/5gQlwcQvjh
$gild another disappointing quarter. Yet reiterates guidance unfortunately long this name for a long time #dead $
RT @tgtxdough: $GILD Gilead has roughly $32B in cash on the balance sheet to do deals. But free cash flow down significantly https://t.co…
$GILD declines in premarket trading. See the latest news. https://t.co/1UjNVlruPT https://t.co/QW8xONsmql
RT @KlendathuCap: @SuperMugatu $GILD just gilding things bro.
@tgtxdough $GILD also have $25B in debt..
RT @tgtxdough: $GILD Gilead has roughly $32B in cash on the balance sheet to do deals. But free cash flow down significantly https://t.co…
$GILD Gilead has roughly $32B in cash on the balance sheet to do deals. But free cash flow down significantly https://t.co/2Gj0J3env5
RT @CaesarBiotech: $GILD Confirmation on Q1 slides: Gilead hbv pipeline is on attrition phase despite Milligan said last year that their ma…
Perelman's AI Trading Algorithm Crashes Gilead Sciences, Micron, and Snapchat $MU $SNAP $GILD #biotech #earnings… https://t.co/pJkHYCfgc9
RT @tgtxdough: MS $GILD Underlying HIV demand was strong (+12%), but inventory was a headwind. While we expect GILD down, we believe underl…
MS $GILD Underlying HIV demand was strong (+12%), but inventory was a headwind. While we expect GILD down, we belie… https://t.co/lX90RLaygU
RT @tgtxdough: MIZHOU $GILD Buy, PT: $95.00, 1Q18 Call Takeaways + Spoke to Company ==> HIV Concerns Overblown, HCV Some Risk We Think
RT @tgtxdough: Baird $GILD Gilead Sciences, Inc. (GILD) Ugly 1Q Raises Questions About What Trough Looks Like Lowering target price to $79…
RT @tgtxdough: Baird $GILD Gilead Sciences, Inc. (GILD) Ugly 1Q Raises Questions About What Trough Looks Like Lowering target price to $79…
Watchlist $GILD $AAP $PSA $CAT https://t.co/q59FitNr7p
16 Stocks To Watch For May 2, 2018 $AAPL $ABC $ADP $CVS $EXC $MA $PRU $HUM $SNAP $ESRX $TSLA $GILD $MET $SFLY $KHC https://t.co/bFpbWoJT9D
$SPY $QQQ $AAPL $AMZN $FB $FPKT $FUJIY $GE $GILD $IAC $LUV $MDLZ $MRK $PFE $RUALF $SAFRY $SNAP $SSNLF $TMUS $UAA https://t.co/FZhbSgW2lk
$SPY $QQQ $AAPL $AMZN $FB $FPKT $GE $GILD $IAC $LUV $RUALF $SAFRY $SNAP $SSNLF $UAL $VZ $WMT https://t.co/lX6gf7ojGS
RT @SA_BioTech: $ABBV $AGEN $AMGN $AZN $BMY $CELG $GILD $GSK $JNJ $JUNO $LLY $MRK $NVS $PFE $REGN $SNY $EVLO https://t.co/ZbUYz8WYJI
Morning Most Tweeted Big Caps, check out Gambiste Top 10: $AMD $FFIV $HAS $GILD $ISRG $CELG $CHTR $FB $BKNG $AAPL https://t.co/lYp5LtitVR
Morning Call For Wednesday, May 2 $JNPR $MLM $BRKS $CRAY $NANO $SFLY $AAPL $BGFV $COHR $GILD $SNAP $MTSI $ZEN $YUMC https://t.co/wvK8YmrE9j
Most Active Premarket $SNAP $AAPL $CHK $MU $TVIX $AVGR $AZN $QQQ $UVXY $USLV $SPY $HCHC $S $MA $CNC $HTBX $GILD… https://t.co/wFkYrOJ4CB
21 Stocks Moving In Wednesday's Pre-Market $HCHC $SIGA $SFLY $NANO $JNPR $AAPL $SNAP $HTBX $SSYS $GILD $TAP $W https://t.co/9qG8ONDsc2
$AAPL $SNAP $GILD $CVS $MA $ESPR $HUM $MU $SQ $YUM https://t.co/UEFk6EpO9q
Morning Poppers (The Fat Fuck Edition) - Dr. Fly $AAPL $SNAP $GILD https://t.co/4Gj5Yksh2l
RT @MarketChmln: Top Decliners in #Premarket Hours $SNAP $GILD $TAP $CMI $UGAZ $MU $STX $UN $GOLD https://t.co/sNm3XHVbGw
Top Decliners in #Premarket Hours $SNAP $GILD $TAP $CMI $UGAZ $MU $STX $UN $GOLD https://t.co/sNm3XHVbGw
$SPY $QQQ $AAPL $GILD $CVS $SNAP $TNX #FederalReserve #FOMC #InterestRates https://t.co/HeU8fLAlME
Top 20 $SPY Pre-Market Volume Leaders: $AAPL $CHK $MU $MA $CNC $S $GILD $MTCH $AMD $BAC $GE $FB $INTC $JNPR $SQ… https://t.co/t1DYzoF2fF
$SPY $QQQ $AAPL $AMZN $FB $FPKT $FUJIY $GE $GILD $IAC $LUV $MDLZ $MRK $PFE $RUALF $SAFRY $SNAP $SSNLF $TMUS $UAA https://t.co/afa9Ax5qfW
$GILD $VRX $TPR $MTCH $MS $GS chart https://t.co/5fVpwSVCaK
RT @trade_nut: PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
PRE Market Movers: $CVS $CVX $EL $GRMN $YUM $ADP $GNRC $HUM $APPL $XRX $SNAP $GILD $TMUS $AMZN $MDLZ $TSLA $JNPR $SFLY
$GILD still down 5% before mrkt open https://t.co/17wI7vuRlY via @business
Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings… https://t.co/yoLbCBrdRg
it's not too late to buy $VRTX .....right $GILD? @adamfeuerstein
$GILD PT lowered to $90 from $95 at Barclays
$GILD whicked illustration of the combo of patient warehousing and pricing competition. I knew it'd be quick, but d… https://t.co/GRFdnoMyn5
RT @odibro: $GILD Reiterated with a buy at Jefferies. $95 PT
RT @OpenOutcrier: $GILD (-5.9% pre) Clock Ticks for Gilead as Earnings Miss Sends Shares Falling - BBG Quint https://t.co/st4mAHNFTD
$GILD (-5.9% pre) Clock Ticks for Gilead as Earnings Miss Sends Shares Falling - BBG Quint https://t.co/st4mAHNFTD
RT @LTbioinvestor: $GILD $ESPR ... another nice day comng in #biotechs ... $IBB $XBI
Top 10 $SPY Pre-Market Leaders: $JNPR $SPGI $PBI $AAPL $ADP $WYN $CHK $GRMN $TER $MA Top 10 $SPY Pre-Market Laggar… https://t.co/yQsOyiZDb7
RT @Benzinga: 21 Stocks Moving In Wednesday's Pre-Market Session https://t.co/xNFFLeayAO $HCHC $SIGA $SFLY $NANO $JNPR $AAPL $SNAP $HTBX $S…
RT @SeekingAlpha: $GSK $GLPG $GILD https://t.co/upznNHRozk
$GSK $GLPG $GILD https://t.co/Rf9BydZpsT
$GSK $GLPG $GILD https://t.co/upznNHRozk
Gilead Sciences $GILD Rating Reiterated by Maxim Group https://t.co/XymlMfd3HW
$GILD Reiterated with a buy at Jefferies. $95 PT
Leerink Swann Reaffirms Market Perform Rating for Gilead Sciences $GILD https://t.co/iHRaaa0dpo
21 Stocks Moving In Wednesday's Pre-Market Session https://t.co/xNFFLeayAO $HCHC $SIGA $SFLY $NANO $JNPR $AAPL… https://t.co/fyygnTYNp2
RT @LTbioinvestor: $GILD $ESPR ... another nice day comng in #biotechs ... $IBB $XBI
RT @AnalystWire: Gilead Sciences $GILD PT Lowered to $79 at Baird https://t.co/BpCri1lcBZ
UP/DOWNGRADES ― $GILD: Maxim Group reits Buy https://t.co/2F1eKgyGd8 via → https://t.co/VS8RO1bzXJ
RT @TradersFish: $GILD stock down -5.60% after hours, stock continues to slide since last year Q1. See our past data recap https://t.co/2HG…
RT @datamonitor_JA: Side by side comparison of Kymriah $NVS and Yescarta $GILD DLBCL labels CR is much high with Yescarta, though Kymriah…
RT @JacobPlieth: If you're trying to figure out the numbers on Kymriah's US DLBCL label this was the state of play at #ASH17 https://t.co/Q…
RT @TimCarmichael3: $GILD LEERINK-- not cheap enough yet ! Q1 falls short & pipeline depends on crowded RA, price target $80 to $72
RT @tatianadariee: $GILD down 6% pre-market https://t.co/zZ3gTG14kN
RT @BioStocks: $GILD PT lowered to $79 from $87 at Baird
RT @tgtxdough: $GILD Gilead has roughly $32B in cash on the balance sheet to do deals. But free cash flow down significantly https://t.co…
$GILD $ESPR ... another nice day comng in #biotechs ... $IBB $XBI
$GILD down 6% pre-market https://t.co/zZ3gTG14kN
RT @BioStocks: $GILD PT lowered to $79 from $87 at Baird
RT @BursatilBiotech: Downgrades arrive at $GILD https://t.co/5OvX8ZmQPG
RT @Jdalexander64: $GILD cc: 1st Question: On R&D side, what areas most excited about to invest in going forward? Answer: "...opportunity…
Explore #fundamental numbers and pros and cons for $GILD https://t.co/IFnkAQiwhE
$GILD PT lowered to $79 from $87 at Baird
I feel the need to share this chart once again with you all. Print it and keep it nearby. Understand why are breakt… https://t.co/QSwXoB70fR
Gilead Sciences $GILD PT Lowered to $79 at Baird https://t.co/BpCri1lcBZ
#TRADING US PM Gapers $AAPL $ALV $MA $NVO $IAC $EVTC $BTI $RIO $FCAU $BUD $FTI $BBL $TS $STM $GLD $X $FXI $SNY… https://t.co/0HjXgNIpOP
RT @adamfeuerstein: $GILD ‘trough year’ looking harder to dig out from after miserable first quarter https://t.co/5gQlwcQvjh
Gilead Sciences Receives a Buy from Maxim Group $GILD https://t.co/zFKebUOjTn
$GILD LEERINK-- not cheap enough yet ! Q1 falls short & pipeline depends on crowded RA, price target $80 to $72

$HAL

2018-04-30 Short volume percent for $OIH is 66%. https://t.co/LRnHGFHcXX $SPY 52% $CVX 35% $HAL 59% $EL 44%
RT @StockRatingsHQ: Wednesday, May 2nd 2018 - Buy, Sell or Hold Ratings Issued For: $FUTL $SSOF $MO $MVES $WFT $FCX $HAL $NOUV $VLDI $ECA $…
Halliburton $HAL Earns Daily Coverage Optimism Score of 0.07 https://t.co/Pmz696971y
Traders Buy Halliburton $HAL on Weakness https://t.co/zdnrA3y2Ne
Traders Buy Halliburton $HAL on Weakness https://t.co/wXkIQfDOKN
Traders Buy Halliburton $HAL on Weakness https://t.co/E9coIp1X46
https://t.co/Ec07V9jf9O $ADCN $LIR $ATX $UTA $BAY $MYST $TCC $SWING $GCN $SKULL $BSTAR $CRM $VAL $RUP $LBTC $IMPS… https://t.co/LpIVxP5tPi
$HAL Max Pain=51.00. Maturity=05/04/2018. #maxpain #options https://t.co/dBRyXS4ZgG https://t.co/CUeNgGnbeM
Short vol percent for $MDR on 2018-05-01 is 77%. https://t.co/6CqYEztcKc $OII 70% $HAL 55% $HLX 52% $SPN 55%
BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY… https://t.co/8RTufi9TZT
RT @BACTop50Cies: BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY $ECL $UNH…
RT @BACTop50Cies: BidaskClub top 50 #StronglyBought $AMZN $NVDA $PEG $SQM $LNT $CDW $HAL $INFY $F $ANTM $BSX $TOT $BBT $SCHW $OXY $ECL $UNH…

$NFX

Newfield Exploration $NFX Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/lWwKqSOD9M
RT @eWhispers: #earnings after the close $AAPL $SNAP $GILD $COHR $TMUS $PAYC $DVN $SU $WATT $APC $BGFV $JNPR $MDLZ $ALL $FTR $WU $MDLP $CH…
Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>… https://t.co/MdU9XiPIHf
#HotStocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>>… https://t.co/80j3gm6czV
#HotStocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>>… https://t.co/xVLTQ8kuth
Newfield Exploration $NFX Posts Earnings Results, Beats Expectations By $0.08 EPS https://t.co/IiH5RE7nc4
Newfield Exploration $NFX Releases Earnings Results, Beats Expectations By $0.08 EPS https://t.co/uiBS8bCxPg
Newfield Exploration $NFX Releases Earnings Results, Beats Expectations By $0.08 EPS https://t.co/AzsRXOnMxn
$NFX reports Q1 2018 Results, stock drops -2.76%, #NewfieldExploration https://t.co/aVSfwRxiao
HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/LqX0PCsORz… https://t.co/0qGkvzKAdi
Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>>… https://t.co/5GPeDTWVTH
RT @pbrat40plus: Hot #Stocks Analysis & Outlook Video for $SGMS $BBY $NFX $AXAS $XRX on our #mtbanalysis Mag >>> https://t.co/LaJu8RUj7I #N…
Brokers Offer Predictions for Newfield Exploration’s FY2019 Earnings $NFX https://t.co/rOskwr9LBv
Jefferies Group Comments on Newfield Exploration’s Q1 2020 Earnings $NFX https://t.co/ZzQqvsY2sa
RT @SeekingAlpha: $MCD $AZO $DG $OKE $CBOE $ALL $HUM $BAX $WM $LMT $PAYX $NEM $T $SO $DUK $LEN $NFX $DVN $ETFC $NKTR $VRTX $AAL $AMD https:…
$MCD $AZO $DG $OKE $CBOE $ALL $HUM $BAX $WM $LMT $PAYX $NEM $T $SO $DUK $LEN $NFX $DVN $ETFC $NKTR $VRTX $AAL $AMD https://t.co/O2bHWaMGxD
2018-05-01 Short volume percent for $DVN is 50%. https://t.co/d7OFae2Gbv $NFX 57% $CHK 69% $BBL 65% $PXD 48%
Williams Capital Reaffirms Their Buy Rating on Newfield $NFX https://t.co/gf0gXfxNgx
$NFX New Form 8-K for Newfield Exploration From our Stock News Alerts App
Jefferies Group Comments on Newfield Exploration’s Q1 2020 Earnings $NFX https://t.co/dM1yg8Kkum
HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/pJd7FAN8Pu… https://t.co/1BvzM5cEG9
The Wednesday post: comments on $PES, $HCLP, $CXO, $RSPP, $VNOM $NFX. Call notes later. Overall very strong. #oil #sand #permian #OOTT
RT @pbrat40plus: HOT #NYSE #Stocks Week 30 Apr - Full Video Analysis & Outlook for $BBY $NFX $XRX >>HERE>> https://t.co/pJd7FAN8Pu #mtbanal…
Jefferies Group Comments on Newfield Exploration’s Q1 2018 Earnings $NFX https://t.co/yP8pOcnwUk
$NFX is Bullish above $29.6. Trade near $29.6 https://t.co/E4fjAvWw6V https://t.co/Sy6DxLZ6qE
Jefferies Group Comments on Newfield Exploration’s Q1 2018 Earnings $NFX https://t.co/MkfVMneYI4
Jefferies Group Sets Newfield Exploration Q1 2018 Earnings Estimates at $0.75 EPS. https://t.co/CWhWkFayPJ $NFX #NFX

¹⁾

quote {symbol AJG companyName {Arthur J. Gallagher & Co.} primaryExchange {New York Stock Exchange} sector {Financial Services} calculationPrice sip open 69.95 openTime 1525181401011 close 69.91 closeTime 1525205025617 high null low null latestPrice 69.91 latestSource {15 minute delayed price} latestTime {8:40:23 AM} latestUpdate 1525264823114 latestVolume 7 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 69.91 delayedPriceTime 1525264823114 previousClose 69.91 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 942309 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 12726826981 peRatio 22.85 week52High 72.77 week52Low 54.5 ytdChange 0.13120963866338947}

²⁾

quote {symbol EXPD companyName {Expeditors International of Washington Inc.} primaryExchange {Nasdaq Global Select} sector Industrials calculationPrice sip open 63.94 openTime 1525181400589 close 64.07 closeTime 1525204800350 high null low null latestPrice 64.07 latestSource {15 minute delayed price} latestTime {8:38:13 AM} latestUpdate 1525264693502 latestVolume 8 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 64.07 delayedPriceTime 1525264693502 previousClose 64.07 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1070455 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 11221779580 peRatio 25.73 week52High 67.63 week52Low 51.96 ytdChange -0.014004309018159598}

³⁾

quote {symbol HP companyName {Helmerich & Payne Inc.} primaryExchange {New York Stock Exchange} sector Energy calculationPrice previousclose open 68.8 openTime 1525181400405 close 68.9 closeTime 1525204901792 high 69.29 low 68.06 latestPrice 68.9 latestSource {Previous close} latestTime {May 1, 2018} latestUpdate 1525132800000 latestVolume 1282957 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 68.745 delayedPriceTime 1525205494119 previousClose 68.9 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1357547 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 7500923347 peRatio -86.13 week52High 75.02 week52Low 42.16 ytdChange 0.06582431997623941}

⁴⁾

quote {symbol JNPR companyName {Juniper Networks Inc.} primaryExchange {New York Stock Exchange} sector Technology calculationPrice sip open 24.38 openTime 1525181400508 close 24.74 closeTime 1525204808060 high null low null latestPrice 26.86 latestSource {15 minute delayed price} latestTime {9:02:43 AM} latestUpdate 1525266163283 latestVolume 94166 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 26.86 delayedPriceTime 1525266163283 previousClose 24.74 change 2.12 changePercent 0.08569 iexMarketPercent 0 iexVolume 0 avgTotalVolume 4271524 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 9374767423 peRatio 15.35 week52High 30.96 week52Low 23.61 ytdChange -0.1379790940766551}

⁵⁾

quote {symbol INCY companyName {Incyte Corporation} primaryExchange {Nasdaq Global Select} sector Healthcare calculationPrice sip open 62 openTime 1525181400268 close 60.85 closeTime 1525204800515 high null low null latestPrice 60.75 latestSource {15 minute delayed price} latestTime {8:58:10 AM} latestUpdate 1525265890866 latestVolume 625 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 60.75 delayedPriceTime 1525265890866 previousClose 60.85 change -0.1 changePercent -0.00164 iexMarketPercent 0 iexVolume 0 avgTotalVolume 3369040 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 12866773394 peRatio -73.19 week52High 140.11 week52Low 60.625 ytdChange -0.3968678759044504}

⁶⁾

quote {symbol BSX companyName {Boston Scientific Corporation} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice sip open 28.74 openTime 1525181409361 close 29.48 closeTime 1525204870285 high null low null latestPrice 29.48 latestSource {15 minute delayed price} latestTime {8:38:13 AM} latestUpdate 1525264693416 latestVolume 7 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 29.48 delayedPriceTime 1525264693416 previousClose 29.48 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 7837609 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 40667518437 peRatio 22.68 week52High 29.93 week52Low 24.54 ytdChange 0.16613924050632908}

⁷⁾

quote {symbol MYL companyName {Mylan N.V.} primaryExchange {Nasdaq Global Select} sector Healthcare calculationPrice sip open 38.56 openTime 1525181400560 close 38.78 closeTime 1525204800503 high null low null latestPrice 38.78 latestSource {15 minute delayed price} latestTime {8:37:41 AM} latestUpdate 1525264661739 latestVolume 9 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 38.78 delayedPriceTime 1525264661739 previousClose 38.78 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 3816077 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 19963234675 peRatio 8.5 week52High 47.82 week52Low 29.39 ytdChange -0.10044073300858265}

⁸⁾

quote {symbol AME companyName {AMETEK Inc.} primaryExchange {New York Stock Exchange} sector Industrials calculationPrice sip open 69.74 openTime 1525181401008 close 69.26 closeTime 1525204925861 high null low null latestPrice 69.5 latestSource {15 minute delayed price} latestTime {9:01:21 AM} latestUpdate 1525266081298 latestVolume 14 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 69.5 delayedPriceTime 1525266081298 previousClose 69.26 change 0.24 changePercent 0.00347 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1200272 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 16091946183 peRatio 26.63 week52High 79.3199 week52Low 57.44 ytdChange -0.0462656190185045}

⁹⁾

quote {symbol WY companyName {Weyerhaeuser Company} primaryExchange {New York Stock Exchange} sector {Basic Materials} calculationPrice previousclose open 36.83 openTime 1525181400904 close 36.39 closeTime 1525204813552 high 36.92 low 36 latestPrice 36.39 latestSource {Previous close} latestTime {May 1, 2018} latestUpdate 1525132800000 latestVolume 6572185 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 36.37 delayedPriceTime 1525206969012 previousClose 36.39 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 4199827 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 27547737822 peRatio 28.21 week52High 37.89 week52Low 30.9504 ytdChange 0.04038310342362952}

¹⁰⁾

quote {symbol A companyName {Agilent Technologies Inc.} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice previousclose open 65.63 openTime 1525181401002 close 66.24 closeTime 1525204873454 high 66.35 low 65.49 latestPrice 66.24 latestSource {Previous close} latestTime {May 1, 2018} latestUpdate 1525132800000 latestVolume 3135127 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 66.041 delayedPriceTime 1525205277875 previousClose 66.24 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 2504763 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 21360848593 peRatio 26.5 week52High 75 week52Low 55.51 ytdChange -0.017931934261929378}

¹¹⁾

quote {symbol HES companyName {Hess Corporation} primaryExchange {New York Stock Exchange} sector Energy calculationPrice sip open 56.54 openTime 1525181400410 close 57.65 closeTime 1525204891421 high null low null latestPrice 57.65 latestSource {15 minute delayed price} latestTime {9:00:27 AM} latestUpdate 1525266027344 latestVolume 11 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 57.65 delayedPriceTime 1525266027344 previousClose 57.65 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 4260177 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 17301508224 peRatio -15.13 week52High 59.56 week52Low 37.25 ytdChange 0.21100215942796152}

¹²⁾

quote {symbol XRX companyName {Xerox Corporation} primaryExchange {New York Stock Exchange} sector Technology calculationPrice sip open 31.35 openTime 1525181400953 close 32.29 closeTime 1525204948111 high null low null latestPrice 32.29 latestSource {15 minute delayed price} latestTime {8:38:13 AM} latestUpdate 1525264693636 latestVolume 5 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 32.29 delayedPriceTime 1525264693636 previousClose 32.29 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 2223517 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 8223406443 peRatio 9.5 week52High 37.42 week52Low 27.18 ytdChange 0.10898175623694903}

¹³⁾

quote {symbol AA companyName {Alcoa Corporation} primaryExchange {New York Stock Exchange} sector {Basic Materials} calculationPrice sip open 51.04 openTime 1525181401003 close 51.99 closeTime 1525204921039 high null low null latestPrice 52.47 latestSource {15 minute delayed price} latestTime {9:02:01 AM} latestUpdate 1525266121313 latestVolume 1416 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 52.47 delayedPriceTime 1525266121313 previousClose 51.99 change 0.48 changePercent 0.00923 iexMarketPercent 0 iexVolume 0 avgTotalVolume 5013313 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 9666303642 peRatio 16.66 week52High 62.35 week52Low 29.55 ytdChange -0.0576400217509516}

¹⁴⁾

quote {symbol GILD companyName {Gilead Sciences Inc.} primaryExchange {Nasdaq Global Select} sector Healthcare calculationPrice sip open 72.29 openTime 1525181400576 close 72.56 closeTime 1525204800332 high null low null latestPrice 68.99 latestSource {15 minute delayed price} latestTime {9:04:13 AM} latestUpdate 1525266253260 latestVolume 204713 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 68.99 delayedPriceTime 1525266253260 previousClose 72.56 change -3.57 changePercent -0.0492 iexMarketPercent 0 iexVolume 0 avgTotalVolume 6085645 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 89952621642 peRatio 8.08 week52High 89.54 week52Low 63.759 ytdChange -0.01385174070933087}

¹⁵⁾

quote {symbol HAL companyName {Halliburton Company} primaryExchange {New York Stock Exchange} sector Energy calculationPrice sip open 52.57 openTime 1525181400355 close 52.44 closeTime 1525204830233 high null low null latestPrice 52.44 latestSource {15 minute delayed price} latestTime {8:38:13 AM} latestUpdate 1525264693494 latestVolume 14 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 52.44 delayedPriceTime 1525264693494 previousClose 52.44 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 8882898 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 45936201944 peRatio 32.98 week52High 57.86 week52Low 38.181 ytdChange 0.061173280450047475}

¹⁶⁾

quote {symbol NFX companyName {Newfield Exploration Company} primaryExchange {New York Stock Exchange} sector Energy calculationPrice sip open 29.51 openTime 1525181400604 close 30.08 closeTime 1525204823696 high null low null latestPrice 30.08 latestSource {15 minute delayed price} latestTime {9:03:54 AM} latestUpdate 1525266234984 latestVolume 360 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 30.08 delayedPriceTime 1525266234984 previousClose 30.08 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 4346237 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 6008270072 peRatio 13.49 week52High 37 week52Low 22.72 ytdChange -0.08571428571428573}

Table of Contents